{"entity":"johnson-johnson","name":"Johnson & Johnson","kind":null,"summary":"Johnson & Johnson's timeline holds 435 claims from 1995 to 2026: 424 money & deals, 11 other. 8 are undated. The latest took effect on October 15, 2026.","counts":{"total":435,"by_kind":{"people":0,"money":424,"products":0,"models":0,"other":11}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson website: https://www.jnj.com\", undated. Claim clm_E1C3F58B38A0, https://asof.is/claim/clm_E1C3F58B38A0, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_E1C3F58B38A0","accessed":"2026-11-08"},"kind":"other","predicate":"website","value":"https://www.jnj.com","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_E1C3F58B38A0","evidence":{"by":"own-site","on":"2026-11-08","quote":"Johnson & Johnson: Changing health for humanity.","url":"https://www.jnj.com"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cik: 0000200406\", undated. Claim clm_0AE18A6EB213, https://asof.is/claim/clm_0AE18A6EB213, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_0AE18A6EB213","accessed":"2026-11-08"},"kind":"other","predicate":"cik","value":"0000200406","status":"valid","assertable":true,"id":"clm_0AE18A6EB213","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson fiscal year end: 01-03\", undated. Claim clm_5254AF4AFDB0, https://asof.is/claim/clm_5254AF4AFDB0, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5254AF4AFDB0","accessed":"2026-11-08"},"kind":"other","predicate":"fiscal_year_end","value":"01-03","status":"valid","assertable":true,"id":"clm_5254AF4AFDB0","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson headquarters: New Brunswick\", undated. Claim clm_5D9D7F332E94, https://asof.is/claim/clm_5D9D7F332E94, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5D9D7F332E94","accessed":"2026-11-08"},"kind":"other","predicate":"headquarters","value":"New Brunswick","status":"valid","assertable":true,"id":"clm_5D9D7F332E94","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_94332C756B27, https://asof.is/claim/clm_94332C756B27, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_94332C756B27","accessed":"2026-11-08"},"kind":"other","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","status":"valid","assertable":true,"id":"clm_94332C756B27","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ticker: JNJ\", undated. Claim clm_AC3F2B6AB463, https://asof.is/claim/clm_AC3F2B6AB463, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_AC3F2B6AB463","accessed":"2026-11-08"},"kind":"other","predicate":"ticker","value":"JNJ","status":"valid","assertable":true,"id":"clm_AC3F2B6AB463","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson listed on: NYSE\", undated. Claim clm_BCF468D9A07B, https://asof.is/claim/clm_BCF468D9A07B, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_BCF468D9A07B","accessed":"2026-11-08"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_BCF468D9A07B","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson state of incorporation: NJ\", undated. Claim clm_CF21B28C04B0, https://asof.is/claim/clm_CF21B28C04B0, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_CF21B28C04B0","accessed":"2026-11-08"},"kind":"other","predicate":"state_of_incorporation","value":"NJ","status":"valid","assertable":true,"id":"clm_CF21B28C04B0","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"1995-10-06","until":"1996-01-23","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson registrant name: JOHNSON & JOHNSON ET AL\", as of 1995-10-06 (until 1996-01-23). Claim clm_53E134305156, https://asof.is/claim/clm_53E134305156, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_53E134305156","accessed":"2026-11-08"},"kind":"other","predicate":"registrant_name","value":"JOHNSON & JOHNSON ET AL","status":"superseded","assertable":true,"id":"clm_53E134305156","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"1996-01-23","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson registrant name: JOHNSON & JOHNSON\", as of 1996-01-23. Claim clm_3F2BC974D10A, https://asof.is/claim/clm_3F2BC974D10A, accessed 2026-11-08. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_3F2BC974D10A","accessed":"2026-11-08"},"kind":"other","predicate":"registrant_name","value":"JOHNSON & JOHNSON","status":"valid","assertable":true,"id":"clm_3F2BC974D10A","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2006-12-31","until":"2007-12-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 39,318,000,000 United States dollar\", as of 2006-12-31 (until 2007-12-30). Claim clm_0ACA43671025, https://asof.is/claim/clm_0ACA43671025, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_0ACA43671025","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"39,318,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0ACA43671025","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2006-12-31","until":"2007-12-30","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 4,083,000,000 United States dollar\", as of 2006-12-31 (until 2007-12-30). Claim clm_E4C51D322876, https://asof.is/claim/clm_E4C51D322876, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_E4C51D322876","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"4,083,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E4C51D322876","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-30","until":"2008-12-28","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 43,319,000,000 United States dollar\", as of 2007-12-30 (until 2008-12-28). Claim clm_3EEF8324595F, https://asof.is/claim/clm_3EEF8324595F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_3EEF8324595F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"43,319,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3EEF8324595F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2007-12-30","until":"2008-06-29","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 7,770,000,000 United States dollar\", as of 2007-12-30 (until 2008-06-29). Claim clm_60D74E1FF6CC, https://asof.is/claim/clm_60D74E1FF6CC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_60D74E1FF6CC","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"7,770,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_60D74E1FF6CC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-06-29","until":"2008-09-28","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 12,646,000,000 United States dollar\", as of 2008-06-29 (until 2008-09-28). Claim clm_068B6BC26FEE, https://asof.is/claim/clm_068B6BC26FEE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309029672/0000950123-09-029672-index.htm.","url":"https://asof.is/claim/clm_068B6BC26FEE","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"12,646,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_068B6BC26FEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2008-09-28","until":"2008-12-28","published":"2009-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,018,000,000 United States dollar\", as of 2008-09-28 (until 2008-12-28). Claim clm_D035CDB434A6, https://asof.is/claim/clm_D035CDB434A6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309057624/0000950123-09-057624-index.htm.","url":"https://asof.is/claim/clm_D035CDB434A6","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,018,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D035CDB434A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-04"}},{"date":"2008-12-28","until":"2009-06-28","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 42,511,000,000 United States dollar\", as of 2008-12-28 (until 2009-06-28). Claim clm_468EE59C8BBF, https://asof.is/claim/clm_468EE59C8BBF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_468EE59C8BBF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"42,511,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_468EE59C8BBF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-28","until":"2009-03-29","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 10,768,000,000 United States dollar\", as of 2008-12-28 (until 2009-03-29). Claim clm_6299E5E1EBBD, https://asof.is/claim/clm_6299E5E1EBBD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_6299E5E1EBBD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"10,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6299E5E1EBBD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2008-12-28","until":"2009-06-28","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 84,912,000,000 United States dollar\", as of 2008-12-28 (until 2009-06-28). Claim clm_B7C7E67D5D2C, https://asof.is/claim/clm_B7C7E67D5D2C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_B7C7E67D5D2C","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"84,912,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7C7E67D5D2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"date":"2009-02-09","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson x username: JNJNews\", as of 2009-02-09. Claim clm_3B23008B4919, https://asof.is/claim/clm_3B23008B4919, accessed 2026-11-08. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_3B23008B4919","accessed":"2026-11-08"},"kind":"other","predicate":"x_username","value":"JNJNews","status":"unverified","assertable":false,"why_not":"unverified","id":"clm_3B23008B4919","evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/JNJNews","url":"https://www.jnj.com"}},{"date":"2009-03-29","until":"2009-06-28","published":"2010-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 12,589,000,000 United States dollar\", as of 2009-03-29 (until 2009-06-28). Claim clm_F36C6CE2C342, https://asof.is/claim/clm_F36C6CE2C342, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310047299/0000950123-10-047299-index.htm.","url":"https://asof.is/claim/clm_F36C6CE2C342","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"12,589,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F36C6CE2C342","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-10"}},{"date":"2009-06-28","until":"2009-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 87,438,000,000 United States dollar\", as of 2009-06-28 (until 2009-09-27). Claim clm_A5C6FFEFEF0E, https://asof.is/claim/clm_A5C6FFEFEF0E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309029672/0000950123-09-029672-index.htm.","url":"https://asof.is/claim/clm_A5C6FFEFEF0E","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"87,438,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5C6FFEFEF0E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-28","until":"2009-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 11,686,000,000 United States dollar\", as of 2009-06-28 (until 2009-09-27). Claim clm_DD0D127ADCE5, https://asof.is/claim/clm_DD0D127ADCE5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309029672/0000950123-09-029672-index.htm.","url":"https://asof.is/claim/clm_DD0D127ADCE5","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"11,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD0D127ADCE5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-28","until":"2009-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 46,247,000,000 United States dollar\", as of 2009-06-28 (until 2009-09-27). Claim clm_F69765E176EB, https://asof.is/claim/clm_F69765E176EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309029672/0000950123-09-029672-index.htm.","url":"https://asof.is/claim/clm_F69765E176EB","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"46,247,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F69765E176EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-07-26","until":"2009-10-25","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,755,813,865 shares\", as of 2009-07-26 (until 2009-10-25). Claim clm_CAE5E6E86B26, https://asof.is/claim/clm_CAE5E6E86B26, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309029672/0000950123-09-029672-index.htm.","url":"https://asof.is/claim/clm_CAE5E6E86B26","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,755,813,865 shares","status":"superseded","assertable":true,"id":"clm_CAE5E6E86B26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-09-27","until":"2010-01-03","published":"2009-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 91,558,000,000 United States dollar\", as of 2009-09-27 (until 2010-01-03). Claim clm_48FA24D0181B, https://asof.is/claim/clm_48FA24D0181B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309057624/0000950123-09-057624-index.htm.","url":"https://asof.is/claim/clm_48FA24D0181B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"91,558,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_48FA24D0181B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-11-04"}},{"date":"2009-09-27","until":"2010-01-03","published":"2009-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 11,856,000,000 United States dollar\", as of 2009-09-27 (until 2010-01-03). Claim clm_6737226071AD, https://asof.is/claim/clm_6737226071AD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309057624/0000950123-09-057624-index.htm.","url":"https://asof.is/claim/clm_6737226071AD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"11,856,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6737226071AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-04"}},{"date":"2009-09-27","until":"2010-01-03","published":"2009-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 50,384,000,000 United States dollar\", as of 2009-09-27 (until 2010-01-03). Claim clm_EBEF52AB23CF, https://asof.is/claim/clm_EBEF52AB23CF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309057624/0000950123-09-057624-index.htm.","url":"https://asof.is/claim/clm_EBEF52AB23CF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"50,384,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EBEF52AB23CF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2009, filed 2009-11-04"}},{"date":"2009-10-25","until":"2010-02-08","published":"2009-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,759,099,726 shares\", as of 2009-10-25 (until 2010-02-08). Claim clm_B25FB0246C58, https://asof.is/claim/clm_B25FB0246C58, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012309057624/0000950123-09-057624-index.htm.","url":"https://asof.is/claim/clm_B25FB0246C58","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,759,099,726 shares","status":"superseded","assertable":true,"id":"clm_B25FB0246C58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-11-04"}},{"date":"2010-01-03","until":"2010-04-04","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 50,588,000,000 United States dollar\", as of 2010-01-03 (until 2010-04-04). Claim clm_2BFDC19E0D41, https://asof.is/claim/clm_2BFDC19E0D41, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_2BFDC19E0D41","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"50,588,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BFDC19E0D41","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-01-03","until":"2010-04-04","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 15,810,000,000 United States dollar\", as of 2010-01-03 (until 2010-04-04). Claim clm_658538EDE6CD, https://asof.is/claim/clm_658538EDE6CD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_658538EDE6CD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"15,810,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_658538EDE6CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-01-03","until":"2011-01-02","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 16,582,000,000 United States dollar\", as of 2010-01-03 (until 2011-01-02). Claim clm_837F3EA18D35, https://asof.is/claim/clm_837F3EA18D35, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_837F3EA18D35","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"16,582,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_837F3EA18D35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-23"}},{"date":"2010-01-03","until":"2010-04-04","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 94,682,000,000 United States dollar\", as of 2010-01-03 (until 2010-04-04). Claim clm_B0F4719AE0EA, https://asof.is/claim/clm_B0F4719AE0EA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_B0F4719AE0EA","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"94,682,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0F4719AE0EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-02-08","until":"2010-05-02","published":"2010-03-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,751,927,062 shares\", as of 2010-02-08 (until 2010-05-02). Claim clm_F91AB87EBD10, https://asof.is/claim/clm_F91AB87EBD10, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310019392/0000950123-10-019392-index.htm.","url":"https://asof.is/claim/clm_F91AB87EBD10","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,751,927,062 shares","status":"superseded","assertable":true,"id":"clm_F91AB87EBD10","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-03-01"}},{"date":"2010-04-04","until":"2010-07-04","published":"2010-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 93,441,000,000 United States dollar\", as of 2010-04-04 (until 2010-07-04). Claim clm_0443D77BCC68, https://asof.is/claim/clm_0443D77BCC68, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310047299/0000950123-10-047299-index.htm.","url":"https://asof.is/claim/clm_0443D77BCC68","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"93,441,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0443D77BCC68","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-10"}},{"date":"2010-04-04","until":"2010-07-04","published":"2010-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 52,914,000,000 United States dollar\", as of 2010-04-04 (until 2010-07-04). Claim clm_46A3C933A0FF, https://asof.is/claim/clm_46A3C933A0FF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310047299/0000950123-10-047299-index.htm.","url":"https://asof.is/claim/clm_46A3C933A0FF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"52,914,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_46A3C933A0FF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2010, filed 2010-05-10"}},{"date":"2010-04-04","until":"2010-07-04","published":"2010-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,743,000,000 United States dollar\", as of 2010-04-04 (until 2010-07-04). Claim clm_AEBE56D4AD76, https://asof.is/claim/clm_AEBE56D4AD76, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310047299/0000950123-10-047299-index.htm.","url":"https://asof.is/claim/clm_AEBE56D4AD76","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AEBE56D4AD76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-10"}},{"date":"2010-05-02","until":"2010-07-30","published":"2010-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,758,069,561 shares\", as of 2010-05-02 (until 2010-07-30). Claim clm_D99C10B4F1E5, https://asof.is/claim/clm_D99C10B4F1E5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310047299/0000950123-10-047299-index.htm.","url":"https://asof.is/claim/clm_D99C10B4F1E5","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,758,069,561 shares","status":"superseded","assertable":true,"id":"clm_D99C10B4F1E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-05-10"}},{"date":"2010-07-04","until":"2010-10-03","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 4,378,000,000 United States dollar\", as of 2010-07-04 (until 2010-10-03). Claim clm_1BD5892BCEFD, https://asof.is/claim/clm_1BD5892BCEFD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_1BD5892BCEFD","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"4,378,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1BD5892BCEFD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2010-07-04","until":"2010-10-03","published":"2010-08-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 12,713,000,000 United States dollar\", as of 2010-07-04 (until 2010-10-03). Claim clm_5529591BE479, https://asof.is/claim/clm_5529591BE479, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310076076/0000950123-10-076076-index.htm.","url":"https://asof.is/claim/clm_5529591BE479","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"12,713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5529591BE479","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-08-11"}},{"date":"2010-07-04","until":"2010-10-03","published":"2010-08-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 52,851,000,000 United States dollar\", as of 2010-07-04 (until 2010-10-03). Claim clm_C148DB7A800F, https://asof.is/claim/clm_C148DB7A800F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310076076/0000950123-10-076076-index.htm.","url":"https://asof.is/claim/clm_C148DB7A800F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"52,851,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C148DB7A800F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2010, filed 2010-08-11"}},{"date":"2010-07-04","until":"2010-10-03","published":"2010-08-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 92,300,000,000 United States dollar\", as of 2010-07-04 (until 2010-10-03). Claim clm_D0560FDBE496, https://asof.is/claim/clm_D0560FDBE496, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310076076/0000950123-10-076076-index.htm.","url":"https://asof.is/claim/clm_D0560FDBE496","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"92,300,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D0560FDBE496","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-08-11"}},{"date":"2010-07-30","until":"2010-10-29","published":"2010-08-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,754,444,672 shares\", as of 2010-07-30 (until 2010-10-29). Claim clm_3FB3FE490FAF, https://asof.is/claim/clm_3FB3FE490FAF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310076076/0000950123-10-076076-index.htm.","url":"https://asof.is/claim/clm_3FB3FE490FAF","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,754,444,672 shares","status":"superseded","assertable":true,"id":"clm_3FB3FE490FAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-08-11"}},{"date":"2010-10-03","until":"2011-01-02","published":"2010-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 98,247,000,000 United States dollar\", as of 2010-10-03 (until 2011-01-02). Claim clm_3637BB22A125, https://asof.is/claim/clm_3637BB22A125, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310103817/0000950123-10-103817-index.htm.","url":"https://asof.is/claim/clm_3637BB22A125","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"98,247,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3637BB22A125","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-10"}},{"date":"2010-10-03","until":"2011-04-03","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 4,361,000,000 United States dollar\", as of 2010-10-03 (until 2011-04-03). Claim clm_3C5D89FAA9CD, https://asof.is/claim/clm_3C5D89FAA9CD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_3C5D89FAA9CD","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"4,361,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C5D89FAA9CD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2010-10-03","until":"2011-01-02","published":"2010-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 57,291,000,000 United States dollar\", as of 2010-10-03 (until 2011-01-02). Claim clm_9CA312FFAA56, https://asof.is/claim/clm_9CA312FFAA56, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310103817/0000950123-10-103817-index.htm.","url":"https://asof.is/claim/clm_9CA312FFAA56","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"57,291,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CA312FFAA56","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2010, filed 2010-11-10"}},{"date":"2010-10-03","until":"2011-01-02","published":"2010-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,338,000,000 United States dollar\", as of 2010-10-03 (until 2011-01-02). Claim clm_EED16A9CA8DD, https://asof.is/claim/clm_EED16A9CA8DD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310103817/0000950123-10-103817-index.htm.","url":"https://asof.is/claim/clm_EED16A9CA8DD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,338,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EED16A9CA8DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-10"}},{"date":"2010-10-29","until":"2011-02-15","published":"2010-11-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,746,253,692 shares\", as of 2010-10-29 (until 2011-02-15). Claim clm_A7362BFF0702, https://asof.is/claim/clm_A7362BFF0702, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012310103817/0000950123-10-103817-index.htm.","url":"https://asof.is/claim/clm_A7362BFF0702","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,746,253,692 shares","status":"superseded","assertable":true,"id":"clm_A7362BFF0702","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-10"}},{"date":"2011-01-02","until":"2011-04-03","published":"2011-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 56,579,000,000 United States dollar\", as of 2011-01-02 (until 2011-04-03). Claim clm_2C867349B81F, https://asof.is/claim/clm_2C867349B81F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311018128/0000950123-11-018128-index.htm.","url":"https://asof.is/claim/clm_2C867349B81F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"56,579,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C867349B81F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2010, filed 2011-02-25"}},{"date":"2011-01-02","until":"2012-01-01","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 17,700,000,000 United States dollar\", as of 2011-01-02 (until 2012-01-01). Claim clm_348C5641157B, https://asof.is/claim/clm_348C5641157B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_348C5641157B","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"17,700,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_348C5641157B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-23"}},{"date":"2011-01-02","until":"2012-01-01","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 13,334,000,000 United States dollar\", as of 2011-01-02 (until 2012-01-01). Claim clm_6518010B6C1D, https://asof.is/claim/clm_6518010B6C1D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_6518010B6C1D","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"13,334,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6518010B6C1D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-22"}},{"date":"2011-01-02","until":"2011-04-03","published":"2011-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 102,908,000,000 United States dollar\", as of 2011-01-02 (until 2011-04-03). Claim clm_7EFECA4604E7, https://asof.is/claim/clm_7EFECA4604E7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311018128/0000950123-11-018128-index.htm.","url":"https://asof.is/claim/clm_7EFECA4604E7","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"102,908,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7EFECA4604E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-25"}},{"date":"2011-01-02","until":"2011-04-03","published":"2011-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,355,000,000 United States dollar\", as of 2011-01-02 (until 2011-04-03). Claim clm_84D390941113, https://asof.is/claim/clm_84D390941113, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311018128/0000950123-11-018128-index.htm.","url":"https://asof.is/claim/clm_84D390941113","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_84D390941113","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-25"}},{"date":"2011-02-15","until":"2011-04-29","published":"2011-02-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,735,213,719 shares\", as of 2011-02-15 (until 2011-04-29). Claim clm_C0A5A0FD5C28, https://asof.is/claim/clm_C0A5A0FD5C28, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311018128/0000950123-11-018128-index.htm.","url":"https://asof.is/claim/clm_C0A5A0FD5C28","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,735,213,719 shares","status":"superseded","assertable":true,"id":"clm_C0A5A0FD5C28","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-25"}},{"date":"2011-04-03","until":"2011-07-03","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 59,863,000,000 United States dollar\", as of 2011-04-03 (until 2011-07-03). Claim clm_071CD3A5E90D, https://asof.is/claim/clm_071CD3A5E90D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311048125/0000950123-11-048125-index.htm.","url":"https://asof.is/claim/clm_071CD3A5E90D","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"59,863,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_071CD3A5E90D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2011, filed 2011-05-10"}},{"date":"2011-04-03","until":"2011-07-03","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 22,356,000,000 United States dollar\", as of 2011-04-03 (until 2011-07-03). Claim clm_76812E74A917, https://asof.is/claim/clm_76812E74A917, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311048125/0000950123-11-048125-index.htm.","url":"https://asof.is/claim/clm_76812E74A917","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"22,356,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76812E74A917","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-10"}},{"date":"2011-04-03","until":"2011-07-03","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 108,150,000,000 United States dollar\", as of 2011-04-03 (until 2011-07-03). Claim clm_8A938D11588F, https://asof.is/claim/clm_8A938D11588F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311048125/0000950123-11-048125-index.htm.","url":"https://asof.is/claim/clm_8A938D11588F","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"108,150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A938D11588F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-10"}},{"date":"2011-04-03","until":"2011-07-03","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 4,726,000,000 United States dollar\", as of 2011-04-03 (until 2011-07-03). Claim clm_EC897C8CCCCB, https://asof.is/claim/clm_EC897C8CCCCB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_EC897C8CCCCB","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"4,726,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC897C8CCCCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2011-04-29","until":"2011-07-29","published":"2011-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,741,143,427 shares\", as of 2011-04-29 (until 2011-07-29). Claim clm_2BCC4D88E0F5, https://asof.is/claim/clm_2BCC4D88E0F5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311048125/0000950123-11-048125-index.htm.","url":"https://asof.is/claim/clm_2BCC4D88E0F5","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,741,143,427 shares","status":"superseded","assertable":true,"id":"clm_2BCC4D88E0F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-10"}},{"date":"2011-07-03","until":"2011-10-02","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 112,114,000,000 United States dollar\", as of 2011-07-03 (until 2011-10-02). Claim clm_08805746B2B4, https://asof.is/claim/clm_08805746B2B4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_08805746B2B4","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"112,114,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_08805746B2B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2011-07-03","until":"2011-10-02","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,974,000,000 United States dollar\", as of 2011-07-03 (until 2011-10-02). Claim clm_132240537F8D, https://asof.is/claim/clm_132240537F8D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_132240537F8D","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,974,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_132240537F8D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2011-07-03","until":"2011-10-02","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 3,538,000,000 United States dollar\", as of 2011-07-03 (until 2011-10-02). Claim clm_28137322AC2A, https://asof.is/claim/clm_28137322AC2A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_28137322AC2A","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"3,538,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28137322AC2A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2011-07-03","until":"2011-10-02","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 62,132,000,000 United States dollar\", as of 2011-07-03 (until 2011-10-02). Claim clm_F88190D1ABCF, https://asof.is/claim/clm_F88190D1ABCF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_F88190D1ABCF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"62,132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F88190D1ABCF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2011-07-29","until":"2011-10-28","published":"2011-08-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,740,354,114 shares\", as of 2011-07-29 (until 2011-10-28). Claim clm_547A2F59E3AC, https://asof.is/claim/clm_547A2F59E3AC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311075098/0000950123-11-075098-index.htm.","url":"https://asof.is/claim/clm_547A2F59E3AC","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,740,354,114 shares","status":"superseded","assertable":true,"id":"clm_547A2F59E3AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-08-09"}},{"date":"2011-10-02","until":"2012-01-01","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 15,617,000,000 United States dollar\", as of 2011-10-02 (until 2012-01-01). Claim clm_01DF4D451D79, https://asof.is/claim/clm_01DF4D451D79, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_01DF4D451D79","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"15,617,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_01DF4D451D79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-10-02","until":"2012-01-01","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 111,821,000,000 United States dollar\", as of 2011-10-02 (until 2012-01-01). Claim clm_3074153C1E76, https://asof.is/claim/clm_3074153C1E76, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_3074153C1E76","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"111,821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3074153C1E76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-10-02","until":"2012-01-01","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 61,527,000,000 United States dollar\", as of 2011-10-02 (until 2012-01-01). Claim clm_490807F68C2F, https://asof.is/claim/clm_490807F68C2F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_490807F68C2F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"61,527,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_490807F68C2F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-10-02","until":"2012-04-01","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,202,000,000 United States dollar\", as of 2011-10-02 (until 2012-04-01). Claim clm_5DA2A254BF19, https://asof.is/claim/clm_5DA2A254BF19, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_5DA2A254BF19","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,202,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5DA2A254BF19","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2011-10-02","until":"2012-04-01","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 4,649,000,000 United States dollar\", as of 2011-10-02 (until 2012-04-01). Claim clm_5EC37F6030EB, https://asof.is/claim/clm_5EC37F6030EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_5EC37F6030EB","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"4,649,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5EC37F6030EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2011-10-28","until":"2012-02-17","published":"2011-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,730,849,018 shares\", as of 2011-10-28 (until 2012-02-17). Claim clm_ED681B2CD584, https://asof.is/claim/clm_ED681B2CD584, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000095012311096471/0000950123-11-096471-index.htm.","url":"https://asof.is/claim/clm_ED681B2CD584","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,730,849,018 shares","status":"superseded","assertable":true,"id":"clm_ED681B2CD584","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-11-08"}},{"date":"2012-01-01","until":"2012-04-01","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 113,644,000,000 United States dollar\", as of 2012-01-01 (until 2012-04-01). Claim clm_07D6B4EAE647, https://asof.is/claim/clm_07D6B4EAE647, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_07D6B4EAE647","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"113,644,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07D6B4EAE647","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-23"}},{"date":"2012-01-01","until":"2012-12-30","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 13,765,000,000 United States dollar\", as of 2012-01-01 (until 2012-12-30). Claim clm_119C70798D30, https://asof.is/claim/clm_119C70798D30, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_119C70798D30","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"13,765,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_119C70798D30","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-23"}},{"date":"2012-01-01","until":"2012-04-01","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 24,542,000,000 United States dollar\", as of 2012-01-01 (until 2012-04-01). Claim clm_DE5B5033175B, https://asof.is/claim/clm_DE5B5033175B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_DE5B5033175B","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"24,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DE5B5033175B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-23"}},{"date":"2012-01-01","until":"2012-04-01","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 57,080,000,000 United States dollar\", as of 2012-01-01 (until 2012-04-01). Claim clm_E634E086C96C, https://asof.is/claim/clm_E634E086C96C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_E634E086C96C","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"57,080,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E634E086C96C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2011, filed 2012-02-23"}},{"date":"2012-01-01","until":"2012-12-30","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 9,672,000,000 United States dollar\", as of 2012-01-01 (until 2012-12-30). Claim clm_FE68183DDB14, https://asof.is/claim/clm_FE68183DDB14, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_FE68183DDB14","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"9,672,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE68183DDB14","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-22"}},{"date":"2012-02-17","until":"2012-04-27","published":"2012-02-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,745,078,671 shares\", as of 2012-02-17 (until 2012-04-27). Claim clm_175824D7635A, https://asof.is/claim/clm_175824D7635A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000119312512075565/0001193125-12-075565-index.htm.","url":"https://asof.is/claim/clm_175824D7635A","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,745,078,671 shares","status":"superseded","assertable":true,"id":"clm_175824D7635A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-23"}},{"date":"2012-04-01","until":"2012-07-01","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 30,267,000,000 United States dollar\", as of 2012-04-01 (until 2012-07-01). Claim clm_2A3250AB5DC8, https://asof.is/claim/clm_2A3250AB5DC8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_2A3250AB5DC8","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"30,267,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A3250AB5DC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2012-04-01","until":"2012-07-01","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 61,366,000,000 United States dollar\", as of 2012-04-01 (until 2012-07-01). Claim clm_887B2718A87E, https://asof.is/claim/clm_887B2718A87E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_887B2718A87E","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"61,366,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_887B2718A87E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2012-04-01","until":"2012-07-01","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,910,000,000 United States dollar\", as of 2012-04-01 (until 2012-07-01). Claim clm_8976A1046276, https://asof.is/claim/clm_8976A1046276, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_8976A1046276","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,910,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8976A1046276","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2012-04-01","until":"2012-07-01","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 116,194,000,000 United States dollar\", as of 2012-04-01 (until 2012-07-01). Claim clm_A5AD1D74BA93, https://asof.is/claim/clm_A5AD1D74BA93, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_A5AD1D74BA93","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"116,194,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A5AD1D74BA93","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2012-04-01","until":"2012-07-01","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,130,000,000 United States dollar\", as of 2012-04-01 (until 2012-07-01). Claim clm_CCF04861C9A5, https://asof.is/claim/clm_CCF04861C9A5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_CCF04861C9A5","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"5,130,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CCF04861C9A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2012-04-27","until":"2012-07-27","published":"2012-05-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,746,372,004 shares\", as of 2012-04-27 (until 2012-07-27). Claim clm_359B289BFAA6, https://asof.is/claim/clm_359B289BFAA6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000081/0000200406-12-000081-index.htm.","url":"https://asof.is/claim/clm_359B289BFAA6","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,746,372,004 shares","status":"superseded","assertable":true,"id":"clm_359B289BFAA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-05-07"}},{"date":"2012-07-01","until":"2012-09-30","published":"2012-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 60,434,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_159A53D01EB3, https://asof.is/claim/clm_159A53D01EB3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000119/0000200406-12-000119-index.htm.","url":"https://asof.is/claim/clm_159A53D01EB3","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"60,434,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_159A53D01EB3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2012, filed 2012-08-02"}},{"date":"2012-07-01","until":"2012-09-30","published":"2012-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 2,657,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_397EAD8BA93F, https://asof.is/claim/clm_397EAD8BA93F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000119/0000200406-12-000119-index.htm.","url":"https://asof.is/claim/clm_397EAD8BA93F","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"2,657,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_397EAD8BA93F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-02"}},{"date":"2012-07-01","until":"2012-09-30","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 16,475,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_42EF4BA66681, https://asof.is/claim/clm_42EF4BA66681, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_42EF4BA66681","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"16,475,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42EF4BA66681","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2012-07-01","until":"2012-09-30","published":"2012-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,042,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_4F69A08513EC, https://asof.is/claim/clm_4F69A08513EC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000119/0000200406-12-000119-index.htm.","url":"https://asof.is/claim/clm_4F69A08513EC","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,042,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4F69A08513EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-02"}},{"date":"2012-07-01","until":"2012-09-30","published":"2012-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 115,750,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_85A81564E8EB, https://asof.is/claim/clm_85A81564E8EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000119/0000200406-12-000119-index.htm.","url":"https://asof.is/claim/clm_85A81564E8EB","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"115,750,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_85A81564E8EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-02"}},{"date":"2012-07-01","until":"2012-09-30","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 1,408,000,000 United States dollar\", as of 2012-07-01 (until 2012-09-30). Claim clm_C174A2B2AA36, https://asof.is/claim/clm_C174A2B2AA36, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_C174A2B2AA36","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"1,408,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C174A2B2AA36","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2012-07-27","until":"2012-10-26","published":"2012-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,757,041,143 shares\", as of 2012-07-27 (until 2012-10-26). Claim clm_E11E66A6CE06, https://asof.is/claim/clm_E11E66A6CE06, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000119/0000200406-12-000119-index.htm.","url":"https://asof.is/claim/clm_E11E66A6CE06","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,757,041,143 shares","status":"superseded","assertable":true,"id":"clm_E11E66A6CE06","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-08-02"}},{"date":"2012-09-30","until":"2012-12-30","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 63,761,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-30). Claim clm_30945DC497A5, https://asof.is/claim/clm_30945DC497A5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_30945DC497A5","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"63,761,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_30945DC497A5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2012-12-30","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 15,486,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-30). Claim clm_470C439ABB24, https://asof.is/claim/clm_470C439ABB24, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_470C439ABB24","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"15,486,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_470C439ABB24","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 3,825,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_6CA780D17F4D, https://asof.is/claim/clm_6CA780D17F4D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_6CA780D17F4D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"3,825,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6CA780D17F4D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2013-03-31","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 17,052,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_6F9C56DBC614, https://asof.is/claim/clm_6F9C56DBC614, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_6F9C56DBC614","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"17,052,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F9C56DBC614","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2012-09-30","until":"2012-12-30","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 118,951,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-30). Claim clm_76F07413B95A, https://asof.is/claim/clm_76F07413B95A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_76F07413B95A","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"118,951,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76F07413B95A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 2,968,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_BCB5B8A8B2D0, https://asof.is/claim/clm_BCB5B8A8B2D0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_BCB5B8A8B2D0","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"2,968,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BCB5B8A8B2D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-10-26","until":"2013-02-19","published":"2012-11-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,771,261,581 shares\", as of 2012-10-26 (until 2013-02-19). Claim clm_3E9973E77AC1, https://asof.is/claim/clm_3E9973E77AC1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040612000140/0000200406-12-000140-index.htm.","url":"https://asof.is/claim/clm_3E9973E77AC1","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,771,261,581 shares","status":"superseded","assertable":true,"id":"clm_3E9973E77AC1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-11-09"}},{"date":"2012-12-30","until":"2013-03-31","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,911,000,000 United States dollar\", as of 2012-12-30 (until 2013-03-31). Claim clm_36CCBBFE010C, https://asof.is/claim/clm_36CCBBFE010C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_36CCBBFE010C","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36CCBBFE010C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-22"}},{"date":"2012-12-30","until":"2013-12-29","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 14,955,000,000 United States dollar\", as of 2012-12-30 (until 2013-12-29). Claim clm_3E2A273419E3, https://asof.is/claim/clm_3E2A273419E3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_3E2A273419E3","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"14,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3E2A273419E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2012, filed 2013-02-22"}},{"date":"2012-12-30","until":"2013-03-31","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 64,826,000,000 United States dollar\", as of 2012-12-30 (until 2013-03-31). Claim clm_B8D56009E3AD, https://asof.is/claim/clm_B8D56009E3AD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_B8D56009E3AD","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"64,826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8D56009E3AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2012, filed 2013-02-22"}},{"date":"2012-12-30","until":"2013-12-29","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 10,853,000,000 United States dollar\", as of 2012-12-30 (until 2013-12-29). Claim clm_C4FCC4CD4712, https://asof.is/claim/clm_C4FCC4CD4712, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_C4FCC4CD4712","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"10,853,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4FCC4CD4712","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2012, filed 2013-02-22"}},{"date":"2012-12-30","until":"2013-03-31","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 121,347,000,000 United States dollar\", as of 2012-12-30 (until 2013-03-31). Claim clm_DF60FCE57A0C, https://asof.is/claim/clm_DF60FCE57A0C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_DF60FCE57A0C","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"121,347,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF60FCE57A0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-22"}},{"date":"2013-02-19","until":"2013-04-26","published":"2013-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,795,319,117 shares\", as of 2013-02-19 (until 2013-04-26). Claim clm_B5DF7A2365E1, https://asof.is/claim/clm_B5DF7A2365E1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000038/0000200406-13-000038-index.htm.","url":"https://asof.is/claim/clm_B5DF7A2365E1","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,795,319,117 shares","status":"superseded","assertable":true,"id":"clm_B5DF7A2365E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-22"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,497,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_103F41CA01F5, https://asof.is/claim/clm_103F41CA01F5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_103F41CA01F5","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,497,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_103F41CA01F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,855,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_2A923EF25166, https://asof.is/claim/clm_2A923EF25166, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_2A923EF25166","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,855,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A923EF25166","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 66,855,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_2E94230F79DA, https://asof.is/claim/clm_2E94230F79DA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_2E94230F79DA","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"66,855,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E94230F79DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 4,482,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_61A73966FCA6, https://asof.is/claim/clm_61A73966FCA6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_61A73966FCA6","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"4,482,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_61A73966FCA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-03-31","until":"2013-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 17,505,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_6F97DEF4B601, https://asof.is/claim/clm_6F97DEF4B601, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_6F97DEF4B601","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"17,505,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F97DEF4B601","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 121,536,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_BE6DDF16BF76, https://asof.is/claim/clm_BE6DDF16BF76, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_BE6DDF16BF76","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"121,536,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE6DDF16BF76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-04-26","until":"2013-07-26","published":"2013-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,808,886,962 shares\", as of 2013-04-26 (until 2013-07-26). Claim clm_53891C0CDD13, https://asof.is/claim/clm_53891C0CDD13, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000057/0000200406-13-000057-index.htm.","url":"https://asof.is/claim/clm_53891C0CDD13","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,808,886,962 shares","status":"superseded","assertable":true,"id":"clm_53891C0CDD13","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-03"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,020,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_3A7C787D23DA, https://asof.is/claim/clm_3A7C787D23DA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_3A7C787D23DA","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"5,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A7C787D23DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,833,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_5E429BDFB114, https://asof.is/claim/clm_5E429BDFB114, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_5E429BDFB114","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,833,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E429BDFB114","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,307,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_69106BFEEEC5, https://asof.is/claim/clm_69106BFEEEC5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_69106BFEEEC5","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,307,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69106BFEEEC5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 17,877,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_7487255D4F9B, https://asof.is/claim/clm_7487255D4F9B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_7487255D4F9B","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"17,877,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7487255D4F9B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 69,665,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_844CD98A1F5C, https://asof.is/claim/clm_844CD98A1F5C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_844CD98A1F5C","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"69,665,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_844CD98A1F5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-06-30","until":"2013-09-29","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 124,325,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-29). Claim clm_CE2F9C7F9194, https://asof.is/claim/clm_CE2F9C7F9194, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_CE2F9C7F9194","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"124,325,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE2F9C7F9194","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-07-26","until":"2013-10-25","published":"2013-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,818,073,863 shares\", as of 2013-07-26 (until 2013-10-25). Claim clm_12BD8B5DBB94, https://asof.is/claim/clm_12BD8B5DBB94, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000091/0000200406-13-000091-index.htm.","url":"https://asof.is/claim/clm_12BD8B5DBB94","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,818,073,863 shares","status":"superseded","assertable":true,"id":"clm_12BD8B5DBB94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-08-01"}},{"date":"2013-09-29","until":"2014-03-30","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 2,982,000,000 United States dollar\", as of 2013-09-29 (until 2014-03-30). Claim clm_32C05FE4ABE2, https://asof.is/claim/clm_32C05FE4ABE2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_32C05FE4ABE2","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"2,982,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32C05FE4ABE2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-09-29","until":"2014-03-30","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 3,872,000,000 United States dollar\", as of 2013-09-29 (until 2014-03-30). Claim clm_5D01336F3C1C, https://asof.is/claim/clm_5D01336F3C1C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_5D01336F3C1C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"3,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D01336F3C1C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-09-29","until":"2013-12-29","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 126,933,000,000 United States dollar\", as of 2013-09-29 (until 2013-12-29). Claim clm_69658153F5B7, https://asof.is/claim/clm_69658153F5B7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_69658153F5B7","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"126,933,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_69658153F5B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-09-29","until":"2013-12-29","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 69,804,000,000 United States dollar\", as of 2013-09-29 (until 2013-12-29). Claim clm_8D9FECCA4C02, https://asof.is/claim/clm_8D9FECCA4C02, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_8D9FECCA4C02","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"69,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D9FECCA4C02","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-09-29","until":"2013-12-29","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,204,000,000 United States dollar\", as of 2013-09-29 (until 2013-12-29). Claim clm_9165FCD822EF, https://asof.is/claim/clm_9165FCD822EF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_9165FCD822EF","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,204,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9165FCD822EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-09-29","until":"2014-03-30","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 17,575,000,000 United States dollar\", as of 2013-09-29 (until 2014-03-30). Claim clm_F4FECC157EBC, https://asof.is/claim/clm_F4FECC157EBC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_F4FECC157EBC","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"17,575,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4FECC157EBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-10-25","until":"2014-02-18","published":"2013-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,821,438,423 shares\", as of 2013-10-25 (until 2014-02-18). Claim clm_A7F9F4372A76, https://asof.is/claim/clm_A7F9F4372A76, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040613000112/0000200406-13-000112-index.htm.","url":"https://asof.is/claim/clm_A7F9F4372A76","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,821,438,423 shares","status":"superseded","assertable":true,"id":"clm_A7F9F4372A76","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-11-04"}},{"date":"2013-12-29","until":"2014-03-30","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 132,683,000,000 United States dollar\", as of 2013-12-29 (until 2014-03-30). Claim clm_64DED7389611, https://asof.is/claim/clm_64DED7389611, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_64DED7389611","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"132,683,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64DED7389611","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-21"}},{"date":"2013-12-29","until":"2014-03-30","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 74,053,000,000 United States dollar\", as of 2013-12-29 (until 2014-03-30). Claim clm_A23F6D781534, https://asof.is/claim/clm_A23F6D781534, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_A23F6D781534","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"74,053,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A23F6D781534","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2013, filed 2014-02-21"}},{"date":"2013-12-29","until":"2014-12-28","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 13,831,000,000 United States dollar\", as of 2013-12-29 (until 2014-12-28). Claim clm_A7D65A0B6000, https://asof.is/claim/clm_A7D65A0B6000, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_A7D65A0B6000","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"13,831,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7D65A0B6000","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2013, filed 2014-02-21"}},{"date":"2013-12-29","until":"2014-12-28","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 16,412,000,000 United States dollar\", as of 2013-12-29 (until 2014-12-28). Claim clm_E94448A285C5, https://asof.is/claim/clm_E94448A285C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_E94448A285C5","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"16,412,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E94448A285C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2013, filed 2014-02-21"}},{"date":"2013-12-29","until":"2014-03-30","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 20,927,000,000 United States dollar\", as of 2013-12-29 (until 2014-03-30). Claim clm_EA437412E6E9, https://asof.is/claim/clm_EA437412E6E9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_EA437412E6E9","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"20,927,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EA437412E6E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-21"}},{"date":"2014-02-18","until":"2014-04-25","published":"2014-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,828,901,694 shares\", as of 2014-02-18 (until 2014-04-25). Claim clm_6013BB800DF5, https://asof.is/claim/clm_6013BB800DF5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000033/0000200406-14-000033-index.htm.","url":"https://asof.is/claim/clm_6013BB800DF5","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,828,901,694 shares","status":"superseded","assertable":true,"id":"clm_6013BB800DF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-21"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 76,582,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_02982D0131BD, https://asof.is/claim/clm_02982D0131BD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_02982D0131BD","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"76,582,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_02982D0131BD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 133,330,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_2EF4B8447879, https://asof.is/claim/clm_2EF4B8447879, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_2EF4B8447879","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"133,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EF4B8447879","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,651,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_914E1773794D, https://asof.is/claim/clm_914E1773794D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_914E1773794D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"5,651,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_914E1773794D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,727,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_95E18D22C257, https://asof.is/claim/clm_95E18D22C257, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_95E18D22C257","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,727,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95E18D22C257","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,722,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_C477080FE76A, https://asof.is/claim/clm_C477080FE76A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_C477080FE76A","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,722,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C477080FE76A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-30","until":"2014-06-29","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 18,115,000,000 United States dollar\", as of 2014-03-30 (until 2014-06-29). Claim clm_DA690338428C, https://asof.is/claim/clm_DA690338428C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_DA690338428C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"18,115,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA690338428C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-04-25","until":"2014-07-25","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,829,099,753 shares\", as of 2014-04-25 (until 2014-07-25). Claim clm_5D3940311C4A, https://asof.is/claim/clm_5D3940311C4A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000047/0000200406-14-000047-index.htm.","url":"https://asof.is/claim/clm_5D3940311C4A","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,829,099,753 shares","status":"superseded","assertable":true,"id":"clm_5D3940311C4A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,875,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_25F7D04B628E, https://asof.is/claim/clm_25F7D04B628E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_25F7D04B628E","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"5,875,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25F7D04B628E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 19,495,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_5CE1ED60A519, https://asof.is/claim/clm_5CE1ED60A519, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_5CE1ED60A519","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"19,495,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5CE1ED60A519","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,236,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_BE347CFB5C80, https://asof.is/claim/clm_BE347CFB5C80, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_BE347CFB5C80","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,236,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE347CFB5C80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 135,200,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_C02ED818C335, https://asof.is/claim/clm_C02ED818C335, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_C02ED818C335","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"135,200,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C02ED818C335","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,326,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_EEBD2E9E1350, https://asof.is/claim/clm_EEBD2E9E1350, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_EEBD2E9E1350","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,326,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEBD2E9E1350","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-06-29","until":"2014-09-28","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 78,048,000,000 United States dollar\", as of 2014-06-29 (until 2014-09-28). Claim clm_F661BC6D3744, https://asof.is/claim/clm_F661BC6D3744, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_F661BC6D3744","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"78,048,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F661BC6D3744","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-07-25","until":"2014-10-24","published":"2014-08-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,820,287,326 shares\", as of 2014-07-25 (until 2014-10-24). Claim clm_B70D999B1504, https://asof.is/claim/clm_B70D999B1504, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000089/0000200406-14-000089-index.htm.","url":"https://asof.is/claim/clm_B70D999B1504","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,820,287,326 shares","status":"superseded","assertable":true,"id":"clm_B70D999B1504","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-08-01"}},{"date":"2014-09-28","until":"2014-12-28","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,818,000,000 United States dollar\", as of 2014-09-28 (until 2014-12-28). Claim clm_08EC02DF19BA, https://asof.is/claim/clm_08EC02DF19BA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_08EC02DF19BA","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,818,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_08EC02DF19BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-09-28","until":"2014-12-28","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 76,591,000,000 United States dollar\", as of 2014-09-28 (until 2014-12-28). Claim clm_1751EA78A840, https://asof.is/claim/clm_1751EA78A840, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_1751EA78A840","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"76,591,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1751EA78A840","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-09-28","until":"2015-03-29","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 7,053,000,000 United States dollar\", as of 2014-09-28 (until 2015-03-29). Claim clm_414BCB52ADAC, https://asof.is/claim/clm_414BCB52ADAC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_414BCB52ADAC","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"7,053,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_414BCB52ADAC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-09-28","until":"2015-03-29","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,749,000,000 United States dollar\", as of 2014-09-28 (until 2015-03-29). Claim clm_44C80D46CC80, https://asof.is/claim/clm_44C80D46CC80, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_44C80D46CC80","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44C80D46CC80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-09-28","until":"2014-12-28","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 132,097,000,000 United States dollar\", as of 2014-09-28 (until 2014-12-28). Claim clm_8B46D91CB023, https://asof.is/claim/clm_8B46D91CB023, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_8B46D91CB023","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"132,097,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B46D91CB023","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-09-28","until":"2017-10-01","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 18,467,000,000 United States dollar\", as of 2014-09-28 (until 2017-10-01). Claim clm_EEE18AA71A3F, https://asof.is/claim/clm_EEE18AA71A3F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_EEE18AA71A3F","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"18,467,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEE18AA71A3F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-10-24","until":"2015-02-17","published":"2014-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,799,110,362 shares\", as of 2014-10-24 (until 2015-02-17). Claim clm_8583892B1416, https://asof.is/claim/clm_8583892B1416, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040614000097/0000200406-14-000097-index.htm.","url":"https://asof.is/claim/clm_8583892B1416","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,799,110,362 shares","status":"superseded","assertable":true,"id":"clm_8583892B1416","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-10-30"}},{"date":"2014-12-28","until":"2015-03-29","published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,523,000,000 United States dollar\", as of 2014-12-28 (until 2015-03-29). Claim clm_016149457CBD, https://asof.is/claim/clm_016149457CBD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_016149457CBD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,523,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_016149457CBD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-24"}},{"date":"2014-12-28","until":"2015-03-29","published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 131,119,000,000 United States dollar\", as of 2014-12-28 (until 2015-03-29). Claim clm_4A4C03B42E5A, https://asof.is/claim/clm_4A4C03B42E5A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_4A4C03B42E5A","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"131,119,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4A4C03B42E5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-24"}},{"date":"2014-12-28","until":"2016-01-03","published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 16,323,000,000 United States dollar\", as of 2014-12-28 (until 2016-01-03). Claim clm_4B6817F9992E, https://asof.is/claim/clm_4B6817F9992E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_4B6817F9992E","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"16,323,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B6817F9992E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2014, filed 2015-02-24"}},{"date":"2014-12-28","until":"2015-03-29","published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 69,752,000,000 United States dollar\", as of 2014-12-28 (until 2015-03-29). Claim clm_744505D820DE, https://asof.is/claim/clm_744505D820DE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_744505D820DE","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"69,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_744505D820DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2014, filed 2015-02-24"}},{"date":"2014-12-28","until":null,"published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 21,590,000,000 United States dollar\", as of 2014-12-28. Claim clm_BAB563999E2E, https://asof.is/claim/clm_BAB563999E2E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_BAB563999E2E","accessed":"2026-11-08"},"kind":"money","predicate":"operating_income","value":"21,590,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_BAB563999E2E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-24"}},{"date":"2015-02-17","until":"2015-04-24","published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,780,488,708 shares\", as of 2015-02-17 (until 2015-04-24). Claim clm_6F259D02B39D, https://asof.is/claim/clm_6F259D02B39D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_6F259D02B39D","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,780,488,708 shares","status":"superseded","assertable":true,"id":"clm_6F259D02B39D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-24"}},{"date":"2015-03-29","until":"2015-06-28","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 11,988,000,000 United States dollar\", as of 2015-03-29 (until 2015-06-28). Claim clm_A61948D8EC4D, https://asof.is/claim/clm_A61948D8EC4D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_A61948D8EC4D","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"11,988,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A61948D8EC4D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-29","until":null,"published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,827,000,000 United States dollar\", as of 2015-03-29. Claim clm_B42FC6E71EE6, https://asof.is/claim/clm_B42FC6E71EE6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_B42FC6E71EE6","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_operating_income","value":"5,827,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B42FC6E71EE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-29","until":"2015-06-28","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 67,878,000,000 United States dollar\", as of 2015-03-29 (until 2015-06-28). Claim clm_C06B690AA5AE, https://asof.is/claim/clm_C06B690AA5AE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_C06B690AA5AE","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"67,878,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C06B690AA5AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-29","until":"2015-06-28","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 128,590,000,000 United States dollar\", as of 2015-03-29 (until 2015-06-28). Claim clm_CD5C8AD01F5A, https://asof.is/claim/clm_CD5C8AD01F5A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_CD5C8AD01F5A","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"128,590,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD5C8AD01F5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-29","until":"2015-06-28","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,320,000,000 United States dollar\", as of 2015-03-29 (until 2015-06-28). Claim clm_CE5EAD8CA8EB, https://asof.is/claim/clm_CE5EAD8CA8EB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_CE5EAD8CA8EB","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,320,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CE5EAD8CA8EB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-04-24","until":"2015-07-24","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,773,045,351 shares\", as of 2015-04-24 (until 2015-07-24). Claim clm_7A498BB1878C, https://asof.is/claim/clm_7A498BB1878C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_7A498BB1878C","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,773,045,351 shares","status":"superseded","assertable":true,"id":"clm_7A498BB1878C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-06-28","until":"2015-09-27","published":"2015-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,131,000,000 United States dollar\", as of 2015-06-28 (until 2015-09-27). Claim clm_4BF40A43696A, https://asof.is/claim/clm_4BF40A43696A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000044/0000200406-15-000044-index.htm.","url":"https://asof.is/claim/clm_4BF40A43696A","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,131,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4BF40A43696A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2015, filed 2015-07-31"}},{"date":"2015-06-28","until":"2015-09-27","published":"2015-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 132,036,000,000 United States dollar\", as of 2015-06-28 (until 2015-09-27). Claim clm_5A76C57B8F7E, https://asof.is/claim/clm_5A76C57B8F7E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000044/0000200406-15-000044-index.htm.","url":"https://asof.is/claim/clm_5A76C57B8F7E","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"132,036,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5A76C57B8F7E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-07-31"}},{"date":"2015-06-28","until":"2015-09-27","published":"2015-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,516,000,000 United States dollar\", as of 2015-06-28 (until 2015-09-27). Claim clm_7772AA9368EF, https://asof.is/claim/clm_7772AA9368EF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000044/0000200406-15-000044-index.htm.","url":"https://asof.is/claim/clm_7772AA9368EF","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,516,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7772AA9368EF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2015, filed 2015-07-31"}},{"date":"2015-06-28","until":"2015-09-27","published":"2015-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 10,639,000,000 United States dollar\", as of 2015-06-28 (until 2015-09-27). Claim clm_EB1D2BBF2782, https://asof.is/claim/clm_EB1D2BBF2782, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000044/0000200406-15-000044-index.htm.","url":"https://asof.is/claim/clm_EB1D2BBF2782","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"10,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB1D2BBF2782","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-07-31"}},{"date":"2015-07-24","until":"2015-10-23","published":"2015-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,769,106,237 shares\", as of 2015-07-24 (until 2015-10-23). Claim clm_5C232D4611BC, https://asof.is/claim/clm_5C232D4611BC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000044/0000200406-15-000044-index.htm.","url":"https://asof.is/claim/clm_5C232D4611BC","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,769,106,237 shares","status":"superseded","assertable":true,"id":"clm_5C232D4611BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-07-31"}},{"date":"2015-09-27","until":"2016-01-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 133,266,000,000 United States dollar\", as of 2015-09-27 (until 2016-01-03). Claim clm_5483CA9F0807, https://asof.is/claim/clm_5483CA9F0807, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000060/0000200406-15-000060-index.htm.","url":"https://asof.is/claim/clm_5483CA9F0807","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"133,266,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5483CA9F0807","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-27","until":"2016-01-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,554,000,000 United States dollar\", as of 2015-09-27 (until 2016-01-03). Claim clm_75D68E8498D0, https://asof.is/claim/clm_75D68E8498D0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000060/0000200406-15-000060-index.htm.","url":"https://asof.is/claim/clm_75D68E8498D0","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,554,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75D68E8498D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-27","until":"2016-04-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,358,000,000 United States dollar\", as of 2015-09-27 (until 2016-04-03). Claim clm_8FC938959ED2, https://asof.is/claim/clm_8FC938959ED2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000060/0000200406-15-000060-index.htm.","url":"https://asof.is/claim/clm_8FC938959ED2","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,358,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8FC938959ED2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-27","until":"2016-01-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,639,000,000 United States dollar\", as of 2015-09-27 (until 2016-01-03). Claim clm_E9AD97C4C3AD, https://asof.is/claim/clm_E9AD97C4C3AD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000060/0000200406-15-000060-index.htm.","url":"https://asof.is/claim/clm_E9AD97C4C3AD","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E9AD97C4C3AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-10-23","until":"2016-02-19","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,766,943,629 shares\", as of 2015-10-23 (until 2016-02-19). Claim clm_5FD86638D6F7, https://asof.is/claim/clm_5FD86638D6F7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000060/0000200406-15-000060-index.htm.","url":"https://asof.is/claim/clm_5FD86638D6F7","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,766,943,629 shares","status":"superseded","assertable":true,"id":"clm_5FD86638D6F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2016-01-03","until":"2016-04-03","published":"2016-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,150,000,000 United States dollar\", as of 2016-01-03 (until 2016-04-03). Claim clm_B1F8EA96665D, https://asof.is/claim/clm_B1F8EA96665D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/0000200406-16-000071-index.htm.","url":"https://asof.is/claim/clm_B1F8EA96665D","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,150,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B1F8EA96665D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2015, filed 2016-02-24"}},{"date":"2016-01-03","until":"2017-01-01","published":"2016-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 15,409,000,000 United States dollar\", as of 2016-01-03 (until 2017-01-01). Claim clm_B8B14C0A5FB9, https://asof.is/claim/clm_B8B14C0A5FB9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/0000200406-16-000071-index.htm.","url":"https://asof.is/claim/clm_B8B14C0A5FB9","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"15,409,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B8B14C0A5FB9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2015, filed 2016-02-24"}},{"date":"2016-01-03","until":"2016-04-03","published":"2016-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 133,411,000,000 United States dollar\", as of 2016-01-03 (until 2016-04-03). Claim clm_BD71F1FBAF6C, https://asof.is/claim/clm_BD71F1FBAF6C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/0000200406-16-000071-index.htm.","url":"https://asof.is/claim/clm_BD71F1FBAF6C","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"133,411,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BD71F1FBAF6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-24"}},{"date":"2016-01-03","until":"2016-04-03","published":"2016-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,732,000,000 United States dollar\", as of 2016-01-03 (until 2016-04-03). Claim clm_DFED29EA0A57, https://asof.is/claim/clm_DFED29EA0A57, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/0000200406-16-000071-index.htm.","url":"https://asof.is/claim/clm_DFED29EA0A57","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,732,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DFED29EA0A57","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-24"}},{"date":"2016-02-19","until":"2016-04-29","published":"2016-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,759,359,192 shares\", as of 2016-02-19 (until 2016-04-29). Claim clm_B5D57C4AEC23, https://asof.is/claim/clm_B5D57C4AEC23, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000071/0000200406-16-000071-index.htm.","url":"https://asof.is/claim/clm_B5D57C4AEC23","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,759,359,192 shares","status":"superseded","assertable":true,"id":"clm_B5D57C4AEC23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-24"}},{"date":"2016-04-03","until":"2016-07-03","published":"2016-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,292,000,000 United States dollar\", as of 2016-04-03 (until 2016-07-03). Claim clm_11D868AAA10D, https://asof.is/claim/clm_11D868AAA10D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/0000200406-16-000084-index.htm.","url":"https://asof.is/claim/clm_11D868AAA10D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,292,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_11D868AAA10D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-10"}},{"date":"2016-04-03","until":"2016-07-03","published":"2016-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 136,231,000,000 United States dollar\", as of 2016-04-03 (until 2016-07-03). Claim clm_181512B76F10, https://asof.is/claim/clm_181512B76F10, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/0000200406-16-000084-index.htm.","url":"https://asof.is/claim/clm_181512B76F10","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"136,231,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_181512B76F10","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-10"}},{"date":"2016-04-03","until":"2016-07-03","published":"2016-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 72,647,000,000 United States dollar\", as of 2016-04-03 (until 2016-07-03). Claim clm_A1CE107B65BD, https://asof.is/claim/clm_A1CE107B65BD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/0000200406-16-000084-index.htm.","url":"https://asof.is/claim/clm_A1CE107B65BD","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"72,647,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A1CE107B65BD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2016, filed 2016-05-10"}},{"date":"2016-04-03","until":"2016-07-03","published":"2016-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,861,000,000 United States dollar\", as of 2016-04-03 (until 2016-07-03). Claim clm_B7A1B304F4EC, https://asof.is/claim/clm_B7A1B304F4EC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/0000200406-16-000084-index.htm.","url":"https://asof.is/claim/clm_B7A1B304F4EC","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,861,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7A1B304F4EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-10"}},{"date":"2016-04-29","until":"2016-07-29","published":"2016-05-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,750,644,288 shares\", as of 2016-04-29 (until 2016-07-29). Claim clm_CC4900DC4BFA, https://asof.is/claim/clm_CC4900DC4BFA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000084/0000200406-16-000084-index.htm.","url":"https://asof.is/claim/clm_CC4900DC4BFA","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,750,644,288 shares","status":"superseded","assertable":true,"id":"clm_CC4900DC4BFA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-05-10"}},{"date":"2016-07-03","until":"2016-10-02","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,640,000,000 United States dollar\", as of 2016-07-03 (until 2016-10-02). Claim clm_2299AA86C480, https://asof.is/claim/clm_2299AA86C480, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000105/0000200406-16-000105-index.htm.","url":"https://asof.is/claim/clm_2299AA86C480","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,640,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2299AA86C480","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-04"}},{"date":"2016-07-03","until":"2016-10-02","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 139,814,000,000 United States dollar\", as of 2016-07-03 (until 2016-10-02). Claim clm_3BFE4F177C1F, https://asof.is/claim/clm_3BFE4F177C1F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000105/0000200406-16-000105-index.htm.","url":"https://asof.is/claim/clm_3BFE4F177C1F","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"139,814,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3BFE4F177C1F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-04"}},{"date":"2016-07-03","until":"2016-10-02","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 72,473,000,000 United States dollar\", as of 2016-07-03 (until 2016-10-02). Claim clm_91F5E40DA8D1, https://asof.is/claim/clm_91F5E40DA8D1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000105/0000200406-16-000105-index.htm.","url":"https://asof.is/claim/clm_91F5E40DA8D1","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"72,473,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_91F5E40DA8D1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2016, filed 2016-08-04"}},{"date":"2016-07-03","until":"2016-10-02","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,997,000,000 United States dollar\", as of 2016-07-03 (until 2016-10-02). Claim clm_E740CED3D9C2, https://asof.is/claim/clm_E740CED3D9C2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000105/0000200406-16-000105-index.htm.","url":"https://asof.is/claim/clm_E740CED3D9C2","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,997,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E740CED3D9C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-04"}},{"date":"2016-07-29","until":"2016-10-28","published":"2016-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,735,876,843 shares\", as of 2016-07-29 (until 2016-10-28). Claim clm_6FBB92AABB37, https://asof.is/claim/clm_6FBB92AABB37, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000105/0000200406-16-000105-index.htm.","url":"https://asof.is/claim/clm_6FBB92AABB37","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,735,876,843 shares","status":"superseded","assertable":true,"id":"clm_6FBB92AABB37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-08-04"}},{"date":"2016-10-02","until":"2017-01-01","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 140,369,000,000 United States dollar\", as of 2016-10-02 (until 2017-01-01). Claim clm_41AB52F22FEB, https://asof.is/claim/clm_41AB52F22FEB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000112/0000200406-16-000112-index.htm.","url":"https://asof.is/claim/clm_41AB52F22FEB","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"140,369,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41AB52F22FEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-04"}},{"date":"2016-10-02","until":"2017-01-01","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 72,769,000,000 United States dollar\", as of 2016-10-02 (until 2017-01-01). Claim clm_75B09F78FA22, https://asof.is/claim/clm_75B09F78FA22, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000112/0000200406-16-000112-index.htm.","url":"https://asof.is/claim/clm_75B09F78FA22","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"72,769,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_75B09F78FA22","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2016, filed 2016-11-04"}},{"date":"2016-10-02","until":"2017-04-02","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,272,000,000 United States dollar\", as of 2016-10-02 (until 2017-04-02). Claim clm_A44B453701A8, https://asof.is/claim/clm_A44B453701A8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000112/0000200406-16-000112-index.htm.","url":"https://asof.is/claim/clm_A44B453701A8","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,272,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A44B453701A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-04"}},{"date":"2016-10-02","until":"2017-01-01","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,205,000,000 United States dollar\", as of 2016-10-02 (until 2017-01-01). Claim clm_A83A001BDC64, https://asof.is/claim/clm_A83A001BDC64, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000112/0000200406-16-000112-index.htm.","url":"https://asof.is/claim/clm_A83A001BDC64","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,205,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A83A001BDC64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-04"}},{"date":"2016-10-28","until":"2017-02-23","published":"2016-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,720,531,728 shares\", as of 2016-10-28 (until 2017-02-23). Claim clm_99A5B7BD8A37, https://asof.is/claim/clm_99A5B7BD8A37, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040616000112/0000200406-16-000112-index.htm.","url":"https://asof.is/claim/clm_99A5B7BD8A37","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,720,531,728 shares","status":"superseded","assertable":true,"id":"clm_99A5B7BD8A37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-11-04"}},{"date":"2017-01-01","until":"2017-04-02","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,418,000,000 United States dollar\", as of 2017-01-01 (until 2017-04-02). Claim clm_1E90C2ECC8CF, https://asof.is/claim/clm_1E90C2ECC8CF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000006/0000200406-17-000006-index.htm.","url":"https://asof.is/claim/clm_1E90C2ECC8CF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,418,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E90C2ECC8CF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2016, filed 2017-02-27"}},{"date":"2017-01-01","until":"2017-04-02","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,972,000,000 United States dollar\", as of 2017-01-01 (until 2017-04-02). Claim clm_97D05077E85F, https://asof.is/claim/clm_97D05077E85F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000006/0000200406-17-000006-index.htm.","url":"https://asof.is/claim/clm_97D05077E85F","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,972,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97D05077E85F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-27"}},{"date":"2017-01-01","until":"2017-12-31","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 16,540,000,000 United States dollar\", as of 2017-01-01 (until 2017-12-31). Claim clm_B61717593C24, https://asof.is/claim/clm_B61717593C24, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000006/0000200406-17-000006-index.htm.","url":"https://asof.is/claim/clm_B61717593C24","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"16,540,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B61717593C24","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-27"}},{"date":"2017-01-01","until":"2017-04-02","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 141,208,000,000 United States dollar\", as of 2017-01-01 (until 2017-04-02). Claim clm_BF8141A8D501, https://asof.is/claim/clm_BF8141A8D501, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000006/0000200406-17-000006-index.htm.","url":"https://asof.is/claim/clm_BF8141A8D501","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"141,208,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF8141A8D501","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-27"}},{"date":"2017-01-01","until":"2017-12-31","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 71,890,000,000 United States dollar\", as of 2017-01-01 (until 2017-12-31). Claim clm_EC592FD5372A, https://asof.is/claim/clm_EC592FD5372A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_EC592FD5372A","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"71,890,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EC592FD5372A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2018, filed 2019-02-20"}},{"date":"2017-02-23","until":"2017-04-28","published":"2017-02-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,713,346,602 shares\", as of 2017-02-23 (until 2017-04-28). Claim clm_9CB0EFA978B9, https://asof.is/claim/clm_9CB0EFA978B9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000006/0000200406-17-000006-index.htm.","url":"https://asof.is/claim/clm_9CB0EFA978B9","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,713,346,602 shares","status":"superseded","assertable":true,"id":"clm_9CB0EFA978B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-27"}},{"date":"2017-04-02","until":"2017-07-02","published":"2017-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 144,918,000,000 United States dollar\", as of 2017-04-02 (until 2017-07-02). Claim clm_05D3C0394C55, https://asof.is/claim/clm_05D3C0394C55, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000024/0000200406-17-000024-index.htm.","url":"https://asof.is/claim/clm_05D3C0394C55","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"144,918,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_05D3C0394C55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-08"}},{"date":"2017-04-02","until":"2017-07-02","published":"2017-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 20,909,000,000 United States dollar\", as of 2017-04-02 (until 2017-07-02). Claim clm_A0F5F0884C24, https://asof.is/claim/clm_A0F5F0884C24, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000024/0000200406-17-000024-index.htm.","url":"https://asof.is/claim/clm_A0F5F0884C24","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"20,909,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0F5F0884C24","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-08"}},{"date":"2017-04-02","until":"2017-07-02","published":"2017-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,422,000,000 United States dollar\", as of 2017-04-02 (until 2017-07-02). Claim clm_DBF5E6A81BF8, https://asof.is/claim/clm_DBF5E6A81BF8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000024/0000200406-17-000024-index.htm.","url":"https://asof.is/claim/clm_DBF5E6A81BF8","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,422,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DBF5E6A81BF8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-08"}},{"date":"2017-04-02","until":"2017-07-02","published":"2017-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,341,000,000 United States dollar\", as of 2017-04-02 (until 2017-07-02). Claim clm_F331B9953B46, https://asof.is/claim/clm_F331B9953B46, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000024/0000200406-17-000024-index.htm.","url":"https://asof.is/claim/clm_F331B9953B46","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,341,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F331B9953B46","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2017, filed 2017-05-08"}},{"date":"2017-04-28","until":"2017-07-28","published":"2017-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,693,833,081 shares\", as of 2017-04-28 (until 2017-07-28). Claim clm_38D615DCD349, https://asof.is/claim/clm_38D615DCD349, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000024/0000200406-17-000024-index.htm.","url":"https://asof.is/claim/clm_38D615DCD349","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,693,833,081 shares","status":"superseded","assertable":true,"id":"clm_38D615DCD349","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-08"}},{"date":"2017-07-02","until":"2017-10-01","published":"2017-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,827,000,000 United States dollar\", as of 2017-07-02 (until 2017-10-01). Claim clm_1D6A897FB85F, https://asof.is/claim/clm_1D6A897FB85F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000042/0000200406-17-000042-index.htm.","url":"https://asof.is/claim/clm_1D6A897FB85F","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,827,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D6A897FB85F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-03"}},{"date":"2017-07-02","until":"2017-10-01","published":"2017-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 12,598,000,000 United States dollar\", as of 2017-07-02 (until 2017-10-01). Claim clm_6F77D365178F, https://asof.is/claim/clm_6F77D365178F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000042/0000200406-17-000042-index.htm.","url":"https://asof.is/claim/clm_6F77D365178F","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"12,598,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F77D365178F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-03"}},{"date":"2017-07-02","until":"2017-10-01","published":"2017-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 152,807,000,000 United States dollar\", as of 2017-07-02 (until 2017-10-01). Claim clm_A3063B24A98E, https://asof.is/claim/clm_A3063B24A98E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000042/0000200406-17-000042-index.htm.","url":"https://asof.is/claim/clm_A3063B24A98E","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"152,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3063B24A98E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-03"}},{"date":"2017-07-02","until":"2017-10-01","published":"2017-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,922,000,000 United States dollar\", as of 2017-07-02 (until 2017-10-01). Claim clm_C85CA222D880, https://asof.is/claim/clm_C85CA222D880, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000042/0000200406-17-000042-index.htm.","url":"https://asof.is/claim/clm_C85CA222D880","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,922,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C85CA222D880","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2017, filed 2017-08-03"}},{"date":"2017-07-28","until":"2017-10-27","published":"2017-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,683,999,728 shares\", as of 2017-07-28 (until 2017-10-27). Claim clm_1820F8AC732C, https://asof.is/claim/clm_1820F8AC732C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000042/0000200406-17-000042-index.htm.","url":"https://asof.is/claim/clm_1820F8AC732C","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,683,999,728 shares","status":"superseded","assertable":true,"id":"clm_1820F8AC732C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-08-03"}},{"date":"2017-10-01","until":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 73,979,000,000 United States dollar\", as of 2017-10-01 (until 2017-12-31). Claim clm_3A8F5DBD499B, https://asof.is/claim/clm_3A8F5DBD499B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000052/0000200406-17-000052-index.htm.","url":"https://asof.is/claim/clm_3A8F5DBD499B","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"73,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A8F5DBD499B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2017, filed 2017-11-02"}},{"date":"2017-10-01","until":"2018-04-01","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 19,650,000,000 United States dollar\", as of 2017-10-01 (until 2018-04-01). Claim clm_3D692F025919, https://asof.is/claim/clm_3D692F025919, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_3D692F025919","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"19,650,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D692F025919","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2017-10-01","until":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,658,000,000 United States dollar\", as of 2017-10-01 (until 2017-12-31). Claim clm_53720CBAA54B, https://asof.is/claim/clm_53720CBAA54B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000052/0000200406-17-000052-index.htm.","url":"https://asof.is/claim/clm_53720CBAA54B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,658,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53720CBAA54B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-02"}},{"date":"2017-10-01","until":"2017-12-31","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 15,721,000,000 United States dollar\", as of 2017-10-01 (until 2017-12-31). Claim clm_DA6A5DFF2612, https://asof.is/claim/clm_DA6A5DFF2612, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000052/0000200406-17-000052-index.htm.","url":"https://asof.is/claim/clm_DA6A5DFF2612","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"15,721,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA6A5DFF2612","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-02"}},{"date":"2017-10-01","until":"2018-04-01","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,764,000,000 United States dollar\", as of 2017-10-01 (until 2018-04-01). Claim clm_DF59A858F022, https://asof.is/claim/clm_DF59A858F022, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000052/0000200406-17-000052-index.htm.","url":"https://asof.is/claim/clm_DF59A858F022","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,764,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF59A858F022","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-02"}},{"date":"2017-10-27","until":"2018-02-16","published":"2017-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,686,520,050 shares\", as of 2017-10-27 (until 2018-02-16). Claim clm_4ACF2BD7F74E, https://asof.is/claim/clm_4ACF2BD7F74E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040617000052/0000200406-17-000052-index.htm.","url":"https://asof.is/claim/clm_4ACF2BD7F74E","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,686,520,050 shares","status":"superseded","assertable":true,"id":"clm_4ACF2BD7F74E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-11-02"}},{"date":"2017-12-31","until":"2018-12-30","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 76,450,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-30). Claim clm_24C72BD0535C, https://asof.is/claim/clm_24C72BD0535C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_24C72BD0535C","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"76,450,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_24C72BD0535C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2018, filed 2019-02-20"}},{"date":"2017-12-31","until":"2018-04-01","published":"2018-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,824,000,000 United States dollar\", as of 2017-12-31 (until 2018-04-01). Claim clm_77A7CF9EA6B1, https://asof.is/claim/clm_77A7CF9EA6B1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm.","url":"https://asof.is/claim/clm_77A7CF9EA6B1","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,824,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77A7CF9EA6B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-21"}},{"date":"2017-12-31","until":"2018-04-01","published":"2018-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 60,160,000,000 United States dollar\", as of 2017-12-31 (until 2018-04-01). Claim clm_9D447D342BB7, https://asof.is/claim/clm_9D447D342BB7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm.","url":"https://asof.is/claim/clm_9D447D342BB7","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"60,160,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D447D342BB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2017, filed 2018-02-21"}},{"date":"2017-12-31","until":"2018-12-30","published":"2018-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 1,300,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-30). Claim clm_9DA338C5F424, https://asof.is/claim/clm_9DA338C5F424, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm.","url":"https://asof.is/claim/clm_9DA338C5F424","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"1,300,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9DA338C5F424","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-21"}},{"date":"2017-12-31","until":"2018-04-01","published":"2018-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 157,303,000,000 United States dollar\", as of 2017-12-31 (until 2018-04-01). Claim clm_F587A7D581E8, https://asof.is/claim/clm_F587A7D581E8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm.","url":"https://asof.is/claim/clm_F587A7D581E8","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"157,303,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F587A7D581E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-21"}},{"date":"2018-02-16","until":"2018-04-26","published":"2018-02-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,682,901,553 shares\", as of 2018-02-16 (until 2018-04-26). Claim clm_1FCFE6DC17E6, https://asof.is/claim/clm_1FCFE6DC17E6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000005/0000200406-18-000005-index.htm.","url":"https://asof.is/claim/clm_1FCFE6DC17E6","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,682,901,553 shares","status":"superseded","assertable":true,"id":"clm_1FCFE6DC17E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-21"}},{"date":"2018-04-01","until":"2018-07-01","published":"2018-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,639,000,000 United States dollar\", as of 2018-04-01 (until 2018-07-01). Claim clm_4243A7972C98, https://asof.is/claim/clm_4243A7972C98, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000019/0000200406-18-000019-index.htm.","url":"https://asof.is/claim/clm_4243A7972C98","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4243A7972C98","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-01"}},{"date":"2018-04-01","until":"2018-07-01","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,009,000,000 United States dollar\", as of 2018-04-01 (until 2018-07-01). Claim clm_74645F257415, https://asof.is/claim/clm_74645F257415, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_74645F257415","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,009,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_74645F257415","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2018-04-01","until":"2018-07-01","published":"2018-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,367,000,000 United States dollar\", as of 2018-04-01 (until 2018-07-01). Claim clm_7CFF284A332D, https://asof.is/claim/clm_7CFF284A332D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000019/0000200406-18-000019-index.htm.","url":"https://asof.is/claim/clm_7CFF284A332D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,367,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7CFF284A332D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-01"}},{"date":"2018-04-01","until":"2018-07-01","published":"2018-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 63,255,000,000 United States dollar\", as of 2018-04-01 (until 2018-07-01). Claim clm_90A6C8E78328, https://asof.is/claim/clm_90A6C8E78328, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000019/0000200406-18-000019-index.htm.","url":"https://asof.is/claim/clm_90A6C8E78328","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"63,255,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_90A6C8E78328","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2018, filed 2018-05-01"}},{"date":"2018-04-01","until":"2018-07-01","published":"2018-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 156,625,000,000 United States dollar\", as of 2018-04-01 (until 2018-07-01). Claim clm_F4E4C13AA092, https://asof.is/claim/clm_F4E4C13AA092, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000019/0000200406-18-000019-index.htm.","url":"https://asof.is/claim/clm_F4E4C13AA092","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"156,625,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4E4C13AA092","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-01"}},{"date":"2018-04-26","until":"2018-07-27","published":"2018-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,682,149,964 shares\", as of 2018-04-26 (until 2018-07-27). Claim clm_793BFC95E65F, https://asof.is/claim/clm_793BFC95E65F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000019/0000200406-18-000019-index.htm.","url":"https://asof.is/claim/clm_793BFC95E65F","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,682,149,964 shares","status":"superseded","assertable":true,"id":"clm_793BFC95E65F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-05-01"}},{"date":"2018-07-01","until":"2018-09-30","published":"2018-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,954,000,000 United States dollar\", as of 2018-07-01 (until 2018-09-30). Claim clm_1B84E439E373, https://asof.is/claim/clm_1B84E439E373, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000041/0000200406-18-000041-index.htm.","url":"https://asof.is/claim/clm_1B84E439E373","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B84E439E373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-02"}},{"date":"2018-07-01","until":"2018-09-30","published":"2018-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,569,000,000 United States dollar\", as of 2018-07-01 (until 2018-09-30). Claim clm_5104634A52DE, https://asof.is/claim/clm_5104634A52DE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000041/0000200406-18-000041-index.htm.","url":"https://asof.is/claim/clm_5104634A52DE","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,569,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5104634A52DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-02"}},{"date":"2018-07-01","until":"2018-09-30","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,830,000,000 United States dollar\", as of 2018-07-01 (until 2018-09-30). Claim clm_B831D08FB7D2, https://asof.is/claim/clm_B831D08FB7D2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_B831D08FB7D2","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,830,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B831D08FB7D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2018-07-01","until":"2018-09-30","published":"2018-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 62,889,000,000 United States dollar\", as of 2018-07-01 (until 2018-09-30). Claim clm_BFD564075E4F, https://asof.is/claim/clm_BFD564075E4F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000041/0000200406-18-000041-index.htm.","url":"https://asof.is/claim/clm_BFD564075E4F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"62,889,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BFD564075E4F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2018, filed 2018-08-02"}},{"date":"2018-07-01","until":"2018-09-30","published":"2018-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,365,000,000 United States dollar\", as of 2018-07-01 (until 2018-09-30). Claim clm_FE713BBEFE84, https://asof.is/claim/clm_FE713BBEFE84, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000041/0000200406-18-000041-index.htm.","url":"https://asof.is/claim/clm_FE713BBEFE84","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,365,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FE713BBEFE84","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-02"}},{"date":"2018-07-27","until":"2018-10-26","published":"2018-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,682,756,061 shares\", as of 2018-07-27 (until 2018-10-26). Claim clm_797E38C3D7E5, https://asof.is/claim/clm_797E38C3D7E5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000041/0000200406-18-000041-index.htm.","url":"https://asof.is/claim/clm_797E38C3D7E5","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,682,756,061 shares","status":"superseded","assertable":true,"id":"clm_797E38C3D7E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-08-02"}},{"date":"2018-09-30","until":"2018-12-30","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 64,626,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-30). Claim clm_77A97ED0F493, https://asof.is/claim/clm_77A97ED0F493, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_77A97ED0F493","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"64,626,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77A97ED0F493","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-09-30","until":"2018-12-30","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 16,056,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-30). Claim clm_77DFABAB2762, https://asof.is/claim/clm_77DFABAB2762, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_77DFABAB2762","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"16,056,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77DFABAB2762","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,934,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_CA6610FFAFA6, https://asof.is/claim/clm_CA6610FFAFA6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_CA6610FFAFA6","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,934,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA6610FFAFA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-09-30","until":"2018-12-30","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,703,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-30). Claim clm_DA2483AF373C, https://asof.is/claim/clm_DA2483AF373C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_DA2483AF373C","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA2483AF373C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,348,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_DD06EDC42C13, https://asof.is/claim/clm_DD06EDC42C13, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_DD06EDC42C13","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,348,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD06EDC42C13","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-10-26","until":"2019-02-15","published":"2018-10-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,681,977,969 shares\", as of 2018-10-26 (until 2019-02-15). Claim clm_CAD75EE76F30, https://asof.is/claim/clm_CAD75EE76F30, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040618000055/0000200406-18-000055-index.htm.","url":"https://asof.is/claim/clm_CAD75EE76F30","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,681,977,969 shares","status":"superseded","assertable":true,"id":"clm_CAD75EE76F30","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-10-31"}},{"date":"2018-12-30","until":"2019-03-31","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,107,000,000 United States dollar\", as of 2018-12-30 (until 2019-03-31). Claim clm_2B7E843AF5CB, https://asof.is/claim/clm_2B7E843AF5CB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_2B7E843AF5CB","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,107,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B7E843AF5CB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-20"}},{"date":"2018-12-30","until":"2019-12-29","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 81,581,000,000 United States dollar\", as of 2018-12-30 (until 2019-12-29). Claim clm_4B4C69A86015, https://asof.is/claim/clm_4B4C69A86015, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_4B4C69A86015","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"81,581,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B4C69A86015","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2018, filed 2019-02-20"}},{"date":"2018-12-30","until":"2019-03-31","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 59,752,000,000 United States dollar\", as of 2018-12-30 (until 2019-03-31). Claim clm_A0E58512A905, https://asof.is/claim/clm_A0E58512A905, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_A0E58512A905","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"59,752,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0E58512A905","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2018, filed 2019-02-20"}},{"date":"2018-12-30","until":"2019-03-31","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 152,954,000,000 United States dollar\", as of 2018-12-30 (until 2019-03-31). Claim clm_B5336D9BFF50, https://asof.is/claim/clm_B5336D9BFF50, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_B5336D9BFF50","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"152,954,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B5336D9BFF50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-20"}},{"date":"2018-12-30","until":"2019-12-29","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 15,297,000,000 United States dollar\", as of 2018-12-30 (until 2019-12-29). Claim clm_ECD4A6DAE4D4, https://asof.is/claim/clm_ECD4A6DAE4D4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_ECD4A6DAE4D4","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"15,297,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECD4A6DAE4D4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-20"}},{"date":"2019-02-15","until":"2019-04-25","published":"2019-02-20","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,663,138,579 shares\", as of 2019-02-15 (until 2019-04-25). Claim clm_DA41E2F10E93, https://asof.is/claim/clm_DA41E2F10E93, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000009/0000200406-19-000009-index.htm.","url":"https://asof.is/claim/clm_DA41E2F10E93","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,663,138,579 shares","status":"superseded","assertable":true,"id":"clm_DA41E2F10E93","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-20"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 150,027,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_6CD0D211D157, https://asof.is/claim/clm_6CD0D211D157, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_6CD0D211D157","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"150,027,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6CD0D211D157","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,749,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_6E2BAEB04116, https://asof.is/claim/clm_6E2BAEB04116, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_6E2BAEB04116","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,749,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E2BAEB04116","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,021,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_AB6403F31533, https://asof.is/claim/clm_AB6403F31533, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_AB6403F31533","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AB6403F31533","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,734,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_AE94DA85E0B4, https://asof.is/claim/clm_AE94DA85E0B4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_AE94DA85E0B4","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,734,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE94DA85E0B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 58,955,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F9860ED10ECF, https://asof.is/claim/clm_F9860ED10ECF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_F9860ED10ECF","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"58,955,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F9860ED10ECF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-04-25","until":"2019-07-24","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,655,055,987 shares\", as of 2019-04-25 (until 2019-07-24). Claim clm_8266149CB96D, https://asof.is/claim/clm_8266149CB96D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000033/0000200406-19-000033-index.htm.","url":"https://asof.is/claim/clm_8266149CB96D","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,655,055,987 shares","status":"superseded","assertable":true,"id":"clm_8266149CB96D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-06-30","until":"2019-09-29","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,562,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-29). Claim clm_0D67C864AC20, https://asof.is/claim/clm_0D67C864AC20, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_0D67C864AC20","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,562,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0D67C864AC20","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-06-30","until":"2019-09-29","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 60,785,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-29). Claim clm_31C36B518E60, https://asof.is/claim/clm_31C36B518E60, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_31C36B518E60","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"60,785,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_31C36B518E60","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-06-30","until":"2019-09-29","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,607,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-29). Claim clm_6CF5C409C8B7, https://asof.is/claim/clm_6CF5C409C8B7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_6CF5C409C8B7","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,607,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6CF5C409C8B7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-06-30","until":"2019-09-29","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,376,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-29). Claim clm_6E63F8647AE0, https://asof.is/claim/clm_6E63F8647AE0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_6E63F8647AE0","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,376,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E63F8647AE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-06-30","until":"2019-09-29","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,117,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-29). Claim clm_719D6FCA5D50, https://asof.is/claim/clm_719D6FCA5D50, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_719D6FCA5D50","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,117,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_719D6FCA5D50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-07-24","until":"2019-10-22","published":"2019-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,639,165,527 shares\", as of 2019-07-24 (until 2019-10-22). Claim clm_AF7709449006, https://asof.is/claim/clm_AF7709449006, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000053/0000200406-19-000053-index.htm.","url":"https://asof.is/claim/clm_AF7709449006","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,639,165,527 shares","status":"superseded","assertable":true,"id":"clm_AF7709449006","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-07-29"}},{"date":"2019-09-29","until":"2020-03-29","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,729,000,000 United States dollar\", as of 2019-09-29 (until 2020-03-29). Claim clm_3F933BD2AC35, https://asof.is/claim/clm_3F933BD2AC35, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_3F933BD2AC35","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,729,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3F933BD2AC35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-09-29","until":"2019-12-29","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,521,000,000 United States dollar\", as of 2019-09-29 (until 2019-12-29). Claim clm_45C2468A606B, https://asof.is/claim/clm_45C2468A606B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_45C2468A606B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,521,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_45C2468A606B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-09-29","until":"2020-03-29","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 1,753,000,000 United States dollar\", as of 2019-09-29 (until 2020-03-29). Claim clm_91336F6432F8, https://asof.is/claim/clm_91336F6432F8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_91336F6432F8","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"1,753,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_91336F6432F8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-09-29","until":"2019-12-29","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 58,210,000,000 United States dollar\", as of 2019-09-29 (until 2019-12-29). Claim clm_C788333FFDF7, https://asof.is/claim/clm_C788333FFDF7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_C788333FFDF7","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"58,210,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C788333FFDF7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-09-29","until":"2019-12-29","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 16,249,000,000 United States dollar\", as of 2019-09-29 (until 2019-12-29). Claim clm_F44AD6111423, https://asof.is/claim/clm_F44AD6111423, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_F44AD6111423","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"16,249,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F44AD6111423","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-10-22","until":"2020-02-10","published":"2019-10-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,631,872,399 shares\", as of 2019-10-22 (until 2020-02-10). Claim clm_256D088D1994, https://asof.is/claim/clm_256D088D1994, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040619000066/0000200406-19-000066-index.htm.","url":"https://asof.is/claim/clm_256D088D1994","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,631,872,399 shares","status":"superseded","assertable":true,"id":"clm_256D088D1994","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-10-28"}},{"date":"2019-12-29","until":"2021-01-03","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 15,119,000,000 United States dollar\", as of 2019-12-29 (until 2021-01-03). Claim clm_1E40407ED245, https://asof.is/claim/clm_1E40407ED245, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_1E40407ED245","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"15,119,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E40407ED245","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-29","until":"2021-01-03","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 82,059,000,000 United States dollar\", as of 2019-12-29 (until 2021-01-03). Claim clm_58042B533CFA, https://asof.is/claim/clm_58042B533CFA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_58042B533CFA","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"82,059,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_58042B533CFA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-29","until":"2020-03-29","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 59,471,000,000 United States dollar\", as of 2019-12-29 (until 2020-03-29). Claim clm_63A9565B4EE7, https://asof.is/claim/clm_63A9565B4EE7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_63A9565B4EE7","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"59,471,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63A9565B4EE7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-29","until":"2020-03-29","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 157,728,000,000 United States dollar\", as of 2019-12-29 (until 2020-03-29). Claim clm_8ABCC464BF48, https://asof.is/claim/clm_8ABCC464BF48, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_8ABCC464BF48","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"157,728,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8ABCC464BF48","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-29","until":"2020-03-29","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,305,000,000 United States dollar\", as of 2019-12-29 (until 2020-03-29). Claim clm_9463DB4A2B34, https://asof.is/claim/clm_9463DB4A2B34, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_9463DB4A2B34","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,305,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9463DB4A2B34","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-18"}},{"date":"2020-02-10","until":"2020-04-22","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,634,721,257 shares\", as of 2020-02-10 (until 2020-04-22). Claim clm_49F7693CE5E2, https://asof.is/claim/clm_49F7693CE5E2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000010/0000200406-20-000010-index.htm.","url":"https://asof.is/claim/clm_49F7693CE5E2","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,634,721,257 shares","status":"superseded","assertable":true,"id":"clm_49F7693CE5E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-18"}},{"date":"2020-03-29","until":"2020-06-28","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,796,000,000 United States dollar\", as of 2020-03-29 (until 2020-06-28). Claim clm_47DF00E6246D, https://asof.is/claim/clm_47DF00E6246D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_47DF00E6246D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,796,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_47DF00E6246D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-03-29","until":"2020-06-28","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 61,294,000,000 United States dollar\", as of 2020-03-29 (until 2020-06-28). Claim clm_8082A01B2CA9, https://asof.is/claim/clm_8082A01B2CA9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_8082A01B2CA9","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"61,294,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8082A01B2CA9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-03-29","until":"2020-06-28","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 20,691,000,000 United States dollar\", as of 2020-03-29 (until 2020-06-28). Claim clm_B2119111BB6C, https://asof.is/claim/clm_B2119111BB6C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_B2119111BB6C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"20,691,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2119111BB6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-03-29","until":"2020-06-28","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 15,530,000,000 United States dollar\", as of 2020-03-29 (until 2020-06-28). Claim clm_CD7B43C54585, https://asof.is/claim/clm_CD7B43C54585, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_CD7B43C54585","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"15,530,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD7B43C54585","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-03-29","until":"2020-06-28","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 155,017,000,000 United States dollar\", as of 2020-03-29 (until 2020-06-28). Claim clm_F94EE03CE9C2, https://asof.is/claim/clm_F94EE03CE9C2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_F94EE03CE9C2","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"155,017,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F94EE03CE9C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-04-22","until":"2020-07-20","published":"2020-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,634,594,535 shares\", as of 2020-04-22 (until 2020-07-20). Claim clm_4FF1687EDFEE, https://asof.is/claim/clm_4FF1687EDFEE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000035/0000200406-20-000035-index.htm.","url":"https://asof.is/claim/clm_4FF1687EDFEE","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,634,594,535 shares","status":"superseded","assertable":true,"id":"clm_4FF1687EDFEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-04-29"}},{"date":"2020-06-28","until":"2020-09-27","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 18,336,000,000 United States dollar\", as of 2020-06-28 (until 2020-09-27). Claim clm_2BE2447AD898, https://asof.is/claim/clm_2BE2447AD898, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_2BE2447AD898","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"18,336,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BE2447AD898","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-06-28","until":"2020-09-27","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 158,380,000,000 United States dollar\", as of 2020-06-28 (until 2020-09-27). Claim clm_7FA58B2AAE4E, https://asof.is/claim/clm_7FA58B2AAE4E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_7FA58B2AAE4E","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"158,380,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7FA58B2AAE4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-06-28","until":"2020-09-27","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,626,000,000 United States dollar\", as of 2020-06-28 (until 2020-09-27). Claim clm_95A1D2F442C4, https://asof.is/claim/clm_95A1D2F442C4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_95A1D2F442C4","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,626,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95A1D2F442C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-06-28","until":"2020-09-27","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 11,174,000,000 United States dollar\", as of 2020-06-28 (until 2020-09-27). Claim clm_977741F2B254, https://asof.is/claim/clm_977741F2B254, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_977741F2B254","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"11,174,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_977741F2B254","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-06-28","until":"2020-09-27","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 62,978,000,000 United States dollar\", as of 2020-06-28 (until 2020-09-27). Claim clm_A725B33841EE, https://asof.is/claim/clm_A725B33841EE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_A725B33841EE","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"62,978,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A725B33841EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-07-20","until":"2020-10-19","published":"2020-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,632,823,475 shares\", as of 2020-07-20 (until 2020-10-19). Claim clm_0CA230E23219, https://asof.is/claim/clm_0CA230E23219, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000050/0000200406-20-000050-index.htm.","url":"https://asof.is/claim/clm_0CA230E23219","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,632,823,475 shares","status":"superseded","assertable":true,"id":"clm_0CA230E23219","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-07-24"}},{"date":"2020-09-27","until":"2021-01-03","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,965,000,000 United States dollar\", as of 2020-09-27 (until 2021-01-03). Claim clm_9DCA0A39E568, https://asof.is/claim/clm_9DCA0A39E568, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_9DCA0A39E568","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,965,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9DCA0A39E568","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2020-09-27","until":"2021-04-04","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,554,000,000 United States dollar\", as of 2020-09-27 (until 2021-04-04). Claim clm_A3266A28A969, https://asof.is/claim/clm_A3266A28A969, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_A3266A28A969","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,554,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3266A28A969","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2020-09-27","until":"2021-01-03","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 64,473,000,000 United States dollar\", as of 2020-09-27 (until 2021-01-03). Claim clm_C5C2916F17EA, https://asof.is/claim/clm_C5C2916F17EA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_C5C2916F17EA","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"64,473,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C5C2916F17EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2020-09-27","until":"2021-01-03","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 170,693,000,000 United States dollar\", as of 2020-09-27 (until 2021-01-03). Claim clm_D2530A0F1733, https://asof.is/claim/clm_D2530A0F1733, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_D2530A0F1733","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"170,693,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D2530A0F1733","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2020-09-27","until":"2021-04-04","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 21,082,000,000 United States dollar\", as of 2020-09-27 (until 2021-04-04). Claim clm_EE9B11ED5636, https://asof.is/claim/clm_EE9B11ED5636, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_EE9B11ED5636","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"21,082,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE9B11ED5636","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2020-10-19","until":"2021-02-16","published":"2020-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,632,542,672 shares\", as of 2020-10-19 (until 2021-02-16). Claim clm_8D405E8B32CE, https://asof.is/claim/clm_8D405E8B32CE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040620000056/0000200406-20-000056-index.htm.","url":"https://asof.is/claim/clm_8D405E8B32CE","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,632,542,672 shares","status":"superseded","assertable":true,"id":"clm_8D405E8B32CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-10-23"}},{"date":"2021-01-03","until":"2021-04-04","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 63,278,000,000 United States dollar\", as of 2021-01-03 (until 2021-04-04). Claim clm_064D1DDBBE46, https://asof.is/claim/clm_064D1DDBBE46, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_064D1DDBBE46","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"63,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_064D1DDBBE46","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-01-03","until":"2021-04-04","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 13,985,000,000 United States dollar\", as of 2021-01-03 (until 2021-04-04). Claim clm_25AE39B5CFE8, https://asof.is/claim/clm_25AE39B5CFE8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_25AE39B5CFE8","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"13,985,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_25AE39B5CFE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-01-03","until":"2022-01-02","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 82,584,000,000 United States dollar\", as of 2021-01-03 (until 2022-01-02). Claim clm_59F4B432CFB0, https://asof.is/claim/clm_59F4B432CFB0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_59F4B432CFB0","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"82,584,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59F4B432CFB0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-01-03","until":"2021-04-04","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 174,894,000,000 United States dollar\", as of 2021-01-03 (until 2021-04-04). Claim clm_9BDF0A333466, https://asof.is/claim/clm_9BDF0A333466, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_9BDF0A333466","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"174,894,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BDF0A333466","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-01-03","until":"2022-01-02","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 14,714,000,000 United States dollar\", as of 2021-01-03 (until 2022-01-02). Claim clm_D4A8B6F6E80F, https://asof.is/claim/clm_D4A8B6F6E80F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_D4A8B6F6E80F","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"14,714,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4A8B6F6E80F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-02-16","until":"2021-04-23","published":"2021-02-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,628,679,824 shares\", as of 2021-02-16 (until 2021-04-23). Claim clm_5D9098DE93B3, https://asof.is/claim/clm_5D9098DE93B3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000008/0000200406-21-000008-index.htm.","url":"https://asof.is/claim/clm_5D9098DE93B3","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,628,679,824 shares","status":"superseded","assertable":true,"id":"clm_5D9098DE93B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-22"}},{"date":"2021-04-04","until":"2021-07-04","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 172,557,000,000 United States dollar\", as of 2021-04-04 (until 2021-07-04). Claim clm_219190EE87E9, https://asof.is/claim/clm_219190EE87E9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_219190EE87E9","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"172,557,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_219190EE87E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-04-04","until":"2021-07-04","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 6,197,000,000 United States dollar\", as of 2021-04-04 (until 2021-07-04). Claim clm_6376B7BA0CF0, https://asof.is/claim/clm_6376B7BA0CF0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_6376B7BA0CF0","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"6,197,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6376B7BA0CF0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-04-04","until":"2021-07-04","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 65,834,000,000 United States dollar\", as of 2021-04-04 (until 2021-07-04). Claim clm_843C1E3F49B5, https://asof.is/claim/clm_843C1E3F49B5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_843C1E3F49B5","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"65,834,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_843C1E3F49B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-04-04","until":"2021-07-04","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 22,321,000,000 United States dollar\", as of 2021-04-04 (until 2021-07-04). Claim clm_B9399684E5E3, https://asof.is/claim/clm_B9399684E5E3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_B9399684E5E3","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"22,321,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B9399684E5E3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-04-04","until":"2021-07-04","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 12,671,000,000 United States dollar\", as of 2021-04-04 (until 2021-07-04). Claim clm_FD082BA66F3C, https://asof.is/claim/clm_FD082BA66F3C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_FD082BA66F3C","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"12,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD082BA66F3C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-04-23","until":"2021-07-23","published":"2021-04-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,633,396,003 shares\", as of 2021-04-23 (until 2021-07-23). Claim clm_F2791B5F97BD, https://asof.is/claim/clm_F2791B5F97BD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000036/0000200406-21-000036-index.htm.","url":"https://asof.is/claim/clm_F2791B5F97BD","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,633,396,003 shares","status":"superseded","assertable":true,"id":"clm_F2791B5F97BD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-04-30"}},{"date":"2021-07-04","until":"2021-10-03","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 69,580,000,000 United States dollar\", as of 2021-07-04 (until 2021-10-03). Claim clm_2AF745EE4A97, https://asof.is/claim/clm_2AF745EE4A97, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_2AF745EE4A97","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"69,580,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2AF745EE4A97","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-07-04","until":"2021-10-03","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 6,278,000,000 United States dollar\", as of 2021-07-04 (until 2021-10-03). Claim clm_3B6517AEE6C9, https://asof.is/claim/clm_3B6517AEE6C9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_3B6517AEE6C9","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"6,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B6517AEE6C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-07-04","until":"2021-10-03","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,312,000,000 United States dollar\", as of 2021-07-04 (until 2021-10-03). Claim clm_4421AF5C7D38, https://asof.is/claim/clm_4421AF5C7D38, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_4421AF5C7D38","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,312,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4421AF5C7D38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-07-04","until":"2021-10-03","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 176,440,000,000 United States dollar\", as of 2021-07-04 (until 2021-10-03). Claim clm_A00DBC88D7EE, https://asof.is/claim/clm_A00DBC88D7EE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_A00DBC88D7EE","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"176,440,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A00DBC88D7EE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-07-04","until":"2021-10-03","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,332,000,000 United States dollar\", as of 2021-07-04 (until 2021-10-03). Claim clm_E1871AF81176, https://asof.is/claim/clm_E1871AF81176, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_E1871AF81176","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,332,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1871AF81176","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-07-23","until":"2021-10-22","published":"2021-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,632,482,092 shares\", as of 2021-07-23 (until 2021-10-22). Claim clm_17F7E660535C, https://asof.is/claim/clm_17F7E660535C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000057/0000200406-21-000057-index.htm.","url":"https://asof.is/claim/clm_17F7E660535C","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,632,482,092 shares","status":"superseded","assertable":true,"id":"clm_17F7E660535C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-07-29"}},{"date":"2021-10-03","until":"2022-01-02","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,272,000,000 United States dollar\", as of 2021-10-03 (until 2022-01-02). Claim clm_2C61BA318318, https://asof.is/claim/clm_2C61BA318318, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_2C61BA318318","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,272,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C61BA318318","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-10-03","until":"2022-01-02","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 179,228,000,000 United States dollar\", as of 2021-10-03 (until 2022-01-02). Claim clm_576EEE2B33BF, https://asof.is/claim/clm_576EEE2B33BF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_576EEE2B33BF","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"179,228,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_576EEE2B33BF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-10-03","until":"2022-04-03","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,338,000,000 United States dollar\", as of 2021-10-03 (until 2022-04-03). Claim clm_7BE7096E3978, https://asof.is/claim/clm_7BE7096E3978, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_7BE7096E3978","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,338,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BE7096E3978","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-10-03","until":"2022-01-02","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 17,604,000,000 United States dollar\", as of 2021-10-03 (until 2022-01-02). Claim clm_BE5B964A3F3D, https://asof.is/claim/clm_BE5B964A3F3D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_BE5B964A3F3D","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"17,604,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BE5B964A3F3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-10-03","until":"2022-04-03","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,667,000,000 United States dollar\", as of 2021-10-03 (until 2022-04-03). Claim clm_C4EB3804675D, https://asof.is/claim/clm_C4EB3804675D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_C4EB3804675D","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,667,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4EB3804675D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2021-10-22","until":"2022-02-10","published":"2021-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,632,596,969 shares\", as of 2021-10-22 (until 2022-02-10). Claim clm_81D73A017CDE, https://asof.is/claim/clm_81D73A017CDE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040621000070/0000200406-21-000070-index.htm.","url":"https://asof.is/claim/clm_81D73A017CDE","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,632,596,969 shares","status":"superseded","assertable":true,"id":"clm_81D73A017CDE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-10-29"}},{"date":"2022-01-02","until":"2022-04-03","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,487,000,000 United States dollar\", as of 2022-01-02 (until 2022-04-03). Claim clm_127E1108872D, https://asof.is/claim/clm_127E1108872D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_127E1108872D","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_127E1108872D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-01-02","until":"2022-04-03","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 74,023,000,000 United States dollar\", as of 2022-01-02 (until 2022-04-03). Claim clm_2071AB47935F, https://asof.is/claim/clm_2071AB47935F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_2071AB47935F","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"74,023,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2071AB47935F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-01-02","until":"2023-01-01","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 93,775,000,000 United States dollar\", as of 2022-01-02 (until 2023-01-01). Claim clm_39975CB3BDC8, https://asof.is/claim/clm_39975CB3BDC8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_39975CB3BDC8","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"93,775,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39975CB3BDC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-01-02","until":"2022-04-03","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 182,018,000,000 United States dollar\", as of 2022-01-02 (until 2022-04-03). Claim clm_4DFD94E2227B, https://asof.is/claim/clm_4DFD94E2227B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_4DFD94E2227B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"182,018,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4DFD94E2227B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-01-02","until":"2023-01-01","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 0 United States dollar\", as of 2022-01-02 (until 2023-01-01). Claim clm_82A628AC4DA2, https://asof.is/claim/clm_82A628AC4DA2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_82A628AC4DA2","accessed":"2026-11-08"},"kind":"money","predicate":"research_and_development","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_82A628AC4DA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-16"}},{"date":"2022-01-02","until":"2023-01-01","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 20,878,000,000 United States dollar\", as of 2022-01-02 (until 2023-01-01). Claim clm_C824366F5280, https://asof.is/claim/clm_C824366F5280, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_C824366F5280","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"20,878,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C824366F5280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-02-10","until":"2022-04-22","published":"2022-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,629,268,158 shares\", as of 2022-02-10 (until 2022-04-22). Claim clm_437F1BCAA5D3, https://asof.is/claim/clm_437F1BCAA5D3, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/0000200406-22-000022-index.htm.","url":"https://asof.is/claim/clm_437F1BCAA5D3","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,629,268,158 shares","status":"superseded","assertable":true,"id":"clm_437F1BCAA5D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-17"}},{"date":"2022-04-03","until":"2022-07-03","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 74,709,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_3B9C6A1F8D5E, https://asof.is/claim/clm_3B9C6A1F8D5E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_3B9C6A1F8D5E","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"74,709,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B9C6A1F8D5E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-04-03","until":"2022-07-03","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 10,463,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_6EDC769E6856, https://asof.is/claim/clm_6EDC769E6856, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_6EDC769E6856","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"10,463,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6EDC769E6856","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-04-03","until":"2022-07-03","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,149,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_9556ED7AD51A, https://asof.is/claim/clm_9556ED7AD51A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_9556ED7AD51A","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,149,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9556ED7AD51A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-04-03","until":"2022-07-03","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 178,355,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_B1F20EAB7853, https://asof.is/claim/clm_B1F20EAB7853, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_B1F20EAB7853","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"178,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B1F20EAB7853","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-04-03","until":"2022-07-03","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,426,000,000 United States dollar\", as of 2022-04-03 (until 2022-07-03). Claim clm_E32E42FD653C, https://asof.is/claim/clm_E32E42FD653C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_E32E42FD653C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,426,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E32E42FD653C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-04-22","until":"2022-07-22","published":"2022-04-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,631,401,804 shares\", as of 2022-04-22 (until 2022-07-22). Claim clm_038031F26723, https://asof.is/claim/clm_038031F26723, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000048/0000200406-22-000048-index.htm.","url":"https://asof.is/claim/clm_038031F26723","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,631,401,804 shares","status":"superseded","assertable":true,"id":"clm_038031F26723","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-04-29"}},{"date":"2022-07-03","until":"2022-10-02","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 10,983,000,000 United States dollar\", as of 2022-07-03 (until 2022-10-02). Claim clm_6F3EE7E28EF2, https://asof.is/claim/clm_6F3EE7E28EF2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_6F3EE7E28EF2","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"10,983,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F3EE7E28EF2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-07-03","until":"2022-10-02","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 177,724,000,000 United States dollar\", as of 2022-07-03 (until 2022-10-02). Claim clm_76DEF1D46942, https://asof.is/claim/clm_76DEF1D46942, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_76DEF1D46942","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"177,724,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76DEF1D46942","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-07-03","until":"2022-10-02","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 24,020,000,000 United States dollar\", as of 2022-07-03 (until 2022-10-02). Claim clm_8AB0CE8C383A, https://asof.is/claim/clm_8AB0CE8C383A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_8AB0CE8C383A","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"24,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8AB0CE8C383A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-07-03","until":"2022-10-02","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,814,000,000 United States dollar\", as of 2022-07-03 (until 2022-10-02). Claim clm_E54E055E387A, https://asof.is/claim/clm_E54E055E387A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_E54E055E387A","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,814,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E54E055E387A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-07-03","until":"2022-10-02","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 76,357,000,000 United States dollar\", as of 2022-07-03 (until 2022-10-02). Claim clm_EF6E012AB4E6, https://asof.is/claim/clm_EF6E012AB4E6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_EF6E012AB4E6","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"76,357,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EF6E012AB4E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-07-22","until":"2022-10-21","published":"2022-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,629,179,895 shares\", as of 2022-07-22 (until 2022-10-21). Claim clm_0C1CB46BDD47, https://asof.is/claim/clm_0C1CB46BDD47, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000071/0000200406-22-000071-index.htm.","url":"https://asof.is/claim/clm_0C1CB46BDD47","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,629,179,895 shares","status":"superseded","assertable":true,"id":"clm_0C1CB46BDD47","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-07-29"}},{"date":"2022-10-02","until":"2023-04-02","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,791,000,000 United States dollar\", as of 2022-10-02 (until 2023-04-02). Claim clm_0156A8D2E159, https://asof.is/claim/clm_0156A8D2E159, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_0156A8D2E159","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,791,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0156A8D2E159","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2022-10-02","until":"2023-01-01","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 74,599,000,000 United States dollar\", as of 2022-10-02 (until 2023-01-01). Claim clm_65E8EC08F0E4, https://asof.is/claim/clm_65E8EC08F0E4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_65E8EC08F0E4","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"74,599,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65E8EC08F0E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2022-10-02","until":"2023-01-01","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 11,355,000,000 United States dollar\", as of 2022-10-02 (until 2023-01-01). Claim clm_7062352E3028, https://asof.is/claim/clm_7062352E3028, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_7062352E3028","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"11,355,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7062352E3028","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2022-10-02","until":"2023-01-01","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 175,124,000,000 United States dollar\", as of 2022-10-02 (until 2023-01-01). Claim clm_E1F57CAC369B, https://asof.is/claim/clm_E1F57CAC369B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_E1F57CAC369B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"175,124,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E1F57CAC369B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2022-10-02","until":"2023-04-02","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,458,000,000 United States dollar\", as of 2022-10-02 (until 2023-04-02). Claim clm_F5102423FA55, https://asof.is/claim/clm_F5102423FA55, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_F5102423FA55","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F5102423FA55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2022-10-21","until":"2023-02-10","published":"2022-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,614,483,607 shares\", as of 2022-10-21 (until 2023-02-10). Claim clm_22D260BD1083, https://asof.is/claim/clm_22D260BD1083, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000086/0000200406-22-000086-index.htm.","url":"https://asof.is/claim/clm_22D260BD1083","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,614,483,607 shares","status":"superseded","assertable":true,"id":"clm_22D260BD1083","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-10-27"}},{"date":"2023-01-01","until":"2023-12-31","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 17,941,000,000 United States dollar\", as of 2023-01-01 (until 2023-12-31). Claim clm_051D41E2A53F, https://asof.is/claim/clm_051D41E2A53F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_051D41E2A53F","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"17,941,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_051D41E2A53F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-01-01","until":"2023-04-02","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 14,127,000,000 United States dollar\", as of 2023-01-01 (until 2023-04-02). Claim clm_0AD7ABC57467, https://asof.is/claim/clm_0AD7ABC57467, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_0AD7ABC57467","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"14,127,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0AD7ABC57467","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-01-01","until":"2023-12-31","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 94,943,000,000 United States dollar\", as of 2023-01-01 (until 2023-12-31). Claim clm_3414C65BBA00, https://asof.is/claim/clm_3414C65BBA00, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_3414C65BBA00","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"94,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3414C65BBA00","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-01-01","until":"2023-04-02","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 187,378,000,000 United States dollar\", as of 2023-01-01 (until 2023-04-02). Claim clm_947BC2111CAF, https://asof.is/claim/clm_947BC2111CAF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_947BC2111CAF","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"187,378,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_947BC2111CAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-01-01","until":"2023-12-31","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 0 United States dollar\", as of 2023-01-01 (until 2023-12-31). Claim clm_9D7E390449DE, https://asof.is/claim/clm_9D7E390449DE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_9D7E390449DE","accessed":"2026-11-08"},"kind":"money","predicate":"research_and_development","value":"0 United States dollar","status":"superseded","assertable":true,"id":"clm_9D7E390449DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-01-01","until":"2023-04-02","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 76,804,000,000 United States dollar\", as of 2023-01-01 (until 2023-04-02). Claim clm_FA081935F71C, https://asof.is/claim/clm_FA081935F71C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_FA081935F71C","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"76,804,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA081935F71C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-02-10","until":"2023-04-21","published":"2023-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,604,286,303 shares\", as of 2023-02-10 (until 2023-04-21). Claim clm_0B22496A7019, https://asof.is/claim/clm_0B22496A7019, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000016/0000200406-23-000016-index.htm.","url":"https://asof.is/claim/clm_0B22496A7019","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,604,286,303 shares","status":"superseded","assertable":true,"id":"clm_0B22496A7019","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-16"}},{"date":"2023-04-02","until":"2023-07-02","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,170,000,000 United States dollar\", as of 2023-04-02 (until 2023-07-02). Claim clm_16AFEE34D286, https://asof.is/claim/clm_16AFEE34D286, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_16AFEE34D286","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,170,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16AFEE34D286","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-04-02","until":"2023-07-02","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 24,746,000,000 United States dollar\", as of 2023-04-02 (until 2023-07-02). Claim clm_76B2CF5C2B3C, https://asof.is/claim/clm_76B2CF5C2B3C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_76B2CF5C2B3C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"24,746,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76B2CF5C2B3C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-04-02","until":"2023-07-02","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: -68,000,000 United States dollar\", as of 2023-04-02 (until 2023-07-02). Claim clm_92D60BAE97D8, https://asof.is/claim/clm_92D60BAE97D8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_92D60BAE97D8","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"-68,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92D60BAE97D8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-04-02","until":"2023-07-02","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,869,000,000 United States dollar\", as of 2023-04-02 (until 2023-07-02). Claim clm_C70F69F8476B, https://asof.is/claim/clm_C70F69F8476B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_C70F69F8476B","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,869,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C70F69F8476B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-04-02","until":"2023-07-02","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 195,969,000,000 United States dollar\", as of 2023-04-02 (until 2023-07-02). Claim clm_D304A99A1188, https://asof.is/claim/clm_D304A99A1188, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_D304A99A1188","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"195,969,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D304A99A1188","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-04-21","until":"2023-07-24","published":"2023-04-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,598,734,075 shares\", as of 2023-04-21 (until 2023-07-24). Claim clm_7FE38D34FDB7, https://asof.is/claim/clm_7FE38D34FDB7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000056/0000200406-23-000056-index.htm.","url":"https://asof.is/claim/clm_7FE38D34FDB7","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,598,734,075 shares","status":"superseded","assertable":true,"id":"clm_7FE38D34FDB7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-04-28"}},{"date":"2023-07-02","until":"2023-10-01","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 75,149,000,000 United States dollar\", as of 2023-07-02 (until 2023-10-01). Claim clm_3D773E7B97E0, https://asof.is/claim/clm_3D773E7B97E0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_3D773E7B97E0","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"75,149,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D773E7B97E0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-07-02","until":"2023-10-01","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 21,183,000,000 United States dollar\", as of 2023-07-02 (until 2023-10-01). Claim clm_52B5A56EE4D2, https://asof.is/claim/clm_52B5A56EE4D2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_52B5A56EE4D2","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"21,183,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_52B5A56EE4D2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-07-02","until":"2023-10-01","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 191,686,000,000 United States dollar\", as of 2023-07-02 (until 2023-10-01). Claim clm_83EB23FD67E9, https://asof.is/claim/clm_83EB23FD67E9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_83EB23FD67E9","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"191,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_83EB23FD67E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-07-02","until":"2023-10-01","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 25,530,000,000 United States dollar\", as of 2023-07-02 (until 2023-10-01). Claim clm_97A678541B72, https://asof.is/claim/clm_97A678541B72, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_97A678541B72","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"25,530,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97A678541B72","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-07-02","until":"2023-10-01","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,144,000,000 United States dollar\", as of 2023-07-02 (until 2023-10-01). Claim clm_B2108C6ABB02, https://asof.is/claim/clm_B2108C6ABB02, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_B2108C6ABB02","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,144,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B2108C6ABB02","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-07-24","until":"2023-10-23","published":"2023-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,598,969,594 shares\", as of 2023-07-24 (until 2023-10-23). Claim clm_17132028A39E, https://asof.is/claim/clm_17132028A39E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000082/0000200406-23-000082-index.htm.","url":"https://asof.is/claim/clm_17132028A39E","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,598,969,594 shares","status":"superseded","assertable":true,"id":"clm_17132028A39E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-07-31"}},{"date":"2023-10-01","until":"2023-12-31","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,228,000,000 United States dollar\", as of 2023-10-01 (until 2023-12-31). Claim clm_1E6C8C59E30D, https://asof.is/claim/clm_1E6C8C59E30D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_1E6C8C59E30D","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,228,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1E6C8C59E30D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-10-01","until":"2024-03-31","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 21,351,000,000 United States dollar\", as of 2023-10-01 (until 2024-03-31). Claim clm_65879BB72EEE, https://asof.is/claim/clm_65879BB72EEE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_65879BB72EEE","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"21,351,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65879BB72EEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-10-01","until":"2024-03-31","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 26,028,000,000 United States dollar\", as of 2023-10-01 (until 2024-03-31). Claim clm_8674D3CA465E, https://asof.is/claim/clm_8674D3CA465E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_8674D3CA465E","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"26,028,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8674D3CA465E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-10-01","until":"2023-12-31","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,728,000,000 United States dollar\", as of 2023-10-01 (until 2023-12-31). Claim clm_CA5A790ADFFF, https://asof.is/claim/clm_CA5A790ADFFF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_CA5A790ADFFF","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,728,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA5A790ADFFF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-10-01","until":"2023-12-31","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 166,061,000,000 United States dollar\", as of 2023-10-01 (until 2023-12-31). Claim clm_F6794B9CB4BB, https://asof.is/claim/clm_F6794B9CB4BB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_F6794B9CB4BB","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"166,061,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F6794B9CB4BB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-10-23","until":"2024-02-09","published":"2023-10-27","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,278,620 shares\", as of 2023-10-23 (until 2024-02-09). Claim clm_B3276CCC9529, https://asof.is/claim/clm_B3276CCC9529, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040623000102/0000200406-23-000102-index.htm.","url":"https://asof.is/claim/clm_B3276CCC9529","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,278,620 shares","status":"superseded","assertable":true,"id":"clm_B3276CCC9529","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-10-27"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 167,558,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_5675B1B8509B, https://asof.is/claim/clm_5675B1B8509B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_5675B1B8509B","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"167,558,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5675B1B8509B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-12-31","until":"2024-12-29","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 483,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-29). Claim clm_5B83A202B191, https://asof.is/claim/clm_5B83A202B191, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_5B83A202B191","accessed":"2026-11-08"},"kind":"money","predicate":"research_and_development","value":"483,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5B83A202B191","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 68,774,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_5C0B8103D0E4, https://asof.is/claim/clm_5C0B8103D0E4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_5C0B8103D0E4","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"68,774,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C0B8103D0E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-12-31","until":"2024-12-29","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 85,159,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-29). Claim clm_6300DBE0E176, https://asof.is/claim/clm_6300DBE0E176, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_6300DBE0E176","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"85,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6300DBE0E176","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-12-31","until":"2024-12-29","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 35,153,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-29). Claim clm_72124FA463F6, https://asof.is/claim/clm_72124FA463F6, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_72124FA463F6","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"35,153,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72124FA463F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-16"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 21,859,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_7AAE6D3F657E, https://asof.is/claim/clm_7AAE6D3F657E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_7AAE6D3F657E","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"21,859,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7AAE6D3F657E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-16"}},{"date":"2024-02-09","until":"2024-04-25","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,408,767,228 shares\", as of 2024-02-09 (until 2024-04-25). Claim clm_6C2BC4DEC229, https://asof.is/claim/clm_6C2BC4DEC229, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000013/0000200406-24-000013-index.htm.","url":"https://asof.is/claim/clm_6C2BC4DEC229","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,408,767,228 shares","status":"superseded","assertable":true,"id":"clm_6C2BC4DEC229","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-16"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,020,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_23E60EECF485, https://asof.is/claim/clm_23E60EECF485, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_23E60EECF485","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,020,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23E60EECF485","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 25,473,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_2B6D5939007C, https://asof.is/claim/clm_2B6D5939007C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_2B6D5939007C","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"25,473,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B6D5939007C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 21,383,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_6B30FD83B744, https://asof.is/claim/clm_6B30FD83B744, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_6B30FD83B744","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"21,383,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6B30FD83B744","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 3,255,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_71F898DCAD58, https://asof.is/claim/clm_71F898DCAD58, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_71F898DCAD58","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"3,255,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_71F898DCAD58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 171,966,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_7D4A88F6C970, https://asof.is/claim/clm_7D4A88F6C970, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_7D4A88F6C970","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"171,966,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7D4A88F6C970","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-04-25","until":"2024-07-19","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,406,679,183 shares\", as of 2024-04-25 (until 2024-07-19). Claim clm_4A614EB9B62A, https://asof.is/claim/clm_4A614EB9B62A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000049/0000200406-24-000049-index.htm.","url":"https://asof.is/claim/clm_4A614EB9B62A","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,406,679,183 shares","status":"superseded","assertable":true,"id":"clm_4A614EB9B62A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-06-30","until":"2024-09-29","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,538,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-29). Claim clm_63E1D5837180, https://asof.is/claim/clm_63E1D5837180, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_63E1D5837180","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,538,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63E1D5837180","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-06-30","until":"2024-09-29","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 24,878,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-29). Claim clm_65A5CE2E13C5, https://asof.is/claim/clm_65A5CE2E13C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_65A5CE2E13C5","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"24,878,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_65A5CE2E13C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-06-30","until":"2024-09-29","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 4,686,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-29). Claim clm_A99DA67F0EEE, https://asof.is/claim/clm_A99DA67F0EEE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_A99DA67F0EEE","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"4,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A99DA67F0EEE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-06-30","until":"2024-09-29","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 22,447,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-29). Claim clm_E210E733741C, https://asof.is/claim/clm_E210E733741C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_E210E733741C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"22,447,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E210E733741C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-06-30","until":"2024-09-29","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 181,088,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-29). Claim clm_FAB0BE4E57C8, https://asof.is/claim/clm_FAB0BE4E57C8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_FAB0BE4E57C8","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"181,088,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FAB0BE4E57C8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-07-19","until":"2024-10-16","published":"2024-07-25","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,243,667 shares\", as of 2024-07-19 (until 2024-10-16). Claim clm_1227D55CC2B9, https://asof.is/claim/clm_1227D55CC2B9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000075/0000200406-24-000075-index.htm.","url":"https://asof.is/claim/clm_1227D55CC2B9","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,243,667 shares","status":"superseded","assertable":true,"id":"clm_1227D55CC2B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-07-25"}},{"date":"2024-09-29","until":"2025-03-30","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 2,694,000,000 United States dollar\", as of 2024-09-29 (until 2025-03-30). Claim clm_1BF35F7BDFCF, https://asof.is/claim/clm_1BF35F7BDFCF, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_1BF35F7BDFCF","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"2,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1BF35F7BDFCF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-09-29","until":"2025-03-30","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 22,471,000,000 United States dollar\", as of 2024-09-29 (until 2025-03-30). Claim clm_49A6B41403C2, https://asof.is/claim/clm_49A6B41403C2, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_49A6B41403C2","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"22,471,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49A6B41403C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-09-29","until":"2024-12-29","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 178,287,000,000 United States dollar\", as of 2024-09-29 (until 2024-12-29). Claim clm_55C5705901AC, https://asof.is/claim/clm_55C5705901AC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_55C5705901AC","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"178,287,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_55C5705901AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-09-29","until":"2024-12-29","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,980,000,000 United States dollar\", as of 2024-09-29 (until 2024-12-29). Claim clm_59AB554EB42F, https://asof.is/claim/clm_59AB554EB42F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_59AB554EB42F","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,980,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59AB554EB42F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-09-29","until":"2024-12-29","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 70,158,000,000 United States dollar\", as of 2024-09-29 (until 2024-12-29). Claim clm_9F646C1B5ABB, https://asof.is/claim/clm_9F646C1B5ABB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_9F646C1B5ABB","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"70,158,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F646C1B5ABB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-10-16","until":"2025-02-06","published":"2024-10-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,622,972 shares\", as of 2024-10-16 (until 2025-02-06). Claim clm_BA5CB9690AE1, https://asof.is/claim/clm_BA5CB9690AE1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040624000096/0000200406-24-000096-index.htm.","url":"https://asof.is/claim/clm_BA5CB9690AE1","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,622,972 shares","status":"superseded","assertable":true,"id":"clm_BA5CB9690AE1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-10-23"}},{"date":"2024-12-29","until":"2025-03-30","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 24,105,000,000 United States dollar\", as of 2024-12-29 (until 2025-03-30). Claim clm_1BA229B76319, https://asof.is/claim/clm_1BA229B76319, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_1BA229B76319","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"24,105,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1BA229B76319","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-13"}},{"date":"2024-12-29","until":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 1,841,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_447FFAF7D0DA, https://asof.is/claim/clm_447FFAF7D0DA, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_447FFAF7D0DA","accessed":"2026-11-08"},"kind":"money","predicate":"research_and_development","value":"1,841,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_447FFAF7D0DA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-13"}},{"date":"2024-12-29","until":"2025-03-30","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 180,104,000,000 United States dollar\", as of 2024-12-29 (until 2025-03-30). Claim clm_553A2C979309, https://asof.is/claim/clm_553A2C979309, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_553A2C979309","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"180,104,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_553A2C979309","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-13"}},{"date":"2024-12-29","until":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 14,066,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_62CFC14840C5, https://asof.is/claim/clm_62CFC14840C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_62CFC14840C5","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"14,066,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_62CFC14840C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-13"}},{"date":"2024-12-29","until":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 88,821,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_948A7BE90437, https://asof.is/claim/clm_948A7BE90437, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_948A7BE90437","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"88,821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_948A7BE90437","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2025-02-13"}},{"date":"2024-12-29","until":"2025-03-30","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 71,490,000,000 United States dollar\", as of 2024-12-29 (until 2025-03-30). Claim clm_9A76DCE7DEC1, https://asof.is/claim/clm_9A76DCE7DEC1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_9A76DCE7DEC1","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"71,490,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A76DCE7DEC1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2024, filed 2025-02-13"}},{"date":"2025-02-06","until":"2025-04-18","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,616,693 shares\", as of 2025-02-06 (until 2025-04-18). Claim clm_171A12EAE19B, https://asof.is/claim/clm_171A12EAE19B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_171A12EAE19B","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,616,693 shares","status":"superseded","assertable":true,"id":"clm_171A12EAE19B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-13"}},{"date":"2025-03-30","until":"2025-06-29","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 38,474,000,000 United States dollar\", as of 2025-03-30 (until 2025-06-29). Claim clm_665564DFFBD8, https://asof.is/claim/clm_665564DFFBD8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_665564DFFBD8","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"38,474,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_665564DFFBD8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-03-30","until":"2025-06-29","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 193,671,000,000 United States dollar\", as of 2025-03-30 (until 2025-06-29). Claim clm_743414C4617A, https://asof.is/claim/clm_743414C4617A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_743414C4617A","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"193,671,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_743414C4617A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-03-30","until":"2025-06-29","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 10,999,000,000 United States dollar\", as of 2025-03-30 (until 2025-06-29). Claim clm_756E7F8F0C87, https://asof.is/claim/clm_756E7F8F0C87, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_756E7F8F0C87","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"10,999,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_756E7F8F0C87","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-03-30","until":"2025-06-29","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 21,893,000,000 United States dollar\", as of 2025-03-30 (until 2025-06-29). Claim clm_A0F645CB8D09, https://asof.is/claim/clm_A0F645CB8D09, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_A0F645CB8D09","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"21,893,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A0F645CB8D09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-03-30","until":"2025-06-29","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 78,109,000,000 United States dollar\", as of 2025-03-30 (until 2025-06-29). Claim clm_AE2CA85670A7, https://asof.is/claim/clm_AE2CA85670A7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_AE2CA85670A7","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"78,109,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE2CA85670A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-04-18","until":"2025-07-18","published":"2025-04-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,406,073,279 shares\", as of 2025-04-18 (until 2025-07-18). Claim clm_038AA593971D, https://asof.is/claim/clm_038AA593971D, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000119/0000200406-25-000119-index.htm.","url":"https://asof.is/claim/clm_038AA593971D","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,406,073,279 shares","status":"superseded","assertable":true,"id":"clm_038AA593971D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-04-23"}},{"date":"2025-06-29","until":"2025-09-28","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,577,000,000 United States dollar\", as of 2025-06-29 (until 2025-09-28). Claim clm_002E93B63D82, https://asof.is/claim/clm_002E93B63D82, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_002E93B63D82","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,577,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_002E93B63D82","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-06-29","until":"2025-09-28","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,743,000,000 United States dollar\", as of 2025-06-29 (until 2025-09-28). Claim clm_0A1850F0F6B1, https://asof.is/claim/clm_0A1850F0F6B1, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_0A1850F0F6B1","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A1850F0F6B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-06-29","until":"2025-09-28","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,537,000,000 United States dollar\", as of 2025-06-29 (until 2025-09-28). Claim clm_2631596E18A4, https://asof.is/claim/clm_2631596E18A4, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_2631596E18A4","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,537,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2631596E18A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-06-29","until":"2025-09-28","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 78,473,000,000 United States dollar\", as of 2025-06-29 (until 2025-09-28). Claim clm_435382C569DE, https://asof.is/claim/clm_435382C569DE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_435382C569DE","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"78,473,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_435382C569DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-06-29","until":"2025-09-28","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 193,389,000,000 United States dollar\", as of 2025-06-29 (until 2025-09-28). Claim clm_5E6796034E23, https://asof.is/claim/clm_5E6796034E23, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_5E6796034E23","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"193,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5E6796034E23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-07-18","until":"2025-10-17","published":"2025-07-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,408,338,872 shares\", as of 2025-07-18 (until 2025-10-17). Claim clm_AD5BFBCE877E, https://asof.is/claim/clm_AD5BFBCE877E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000178/0000200406-25-000178-index.htm.","url":"https://asof.is/claim/clm_AD5BFBCE877E","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,408,338,872 shares","status":"superseded","assertable":true,"id":"clm_AD5BFBCE877E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-07-24"}},{"date":"2025-09-28","until":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,152,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_4AB4EF856D4C, https://asof.is/claim/clm_4AB4EF856D4C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_4AB4EF856D4C","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,152,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4AB4EF856D4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-09-28","until":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 79,277,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_63969A827BEB, https://asof.is/claim/clm_63969A827BEB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_63969A827BEB","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"79,277,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63969A827BEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-09-28","until":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,993,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_729D980FE153, https://asof.is/claim/clm_729D980FE153, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_729D980FE153","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"23,993,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_729D980FE153","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-09-28","until":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 192,816,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_7E3589121DB9, https://asof.is/claim/clm_7E3589121DB9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_7E3589121DB9","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"192,816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E3589121DB9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-09-28","until":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,231,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_A4F230EF9BBB, https://asof.is/claim/clm_A4F230EF9BBB, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_A4F230EF9BBB","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"18,231,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A4F230EF9BBB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-10-17","until":"2026-02-06","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,295,102 shares\", as of 2025-10-17 (until 2026-02-06). Claim clm_D97FEC131483, https://asof.is/claim/clm_D97FEC131483, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_D97FEC131483","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,409,295,102 shares","status":"superseded","assertable":true,"id":"clm_D97FEC131483","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-22"}},{"date":"2025-12-28","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 26,804,000,000 United States dollar\", as of 2025-12-28. Claim clm_04E6B87CA267, https://asof.is/claim/clm_04E6B87CA267, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_04E6B87CA267","accessed":"2026-11-08"},"kind":"money","predicate":"net_income","value":"26,804,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_04E6B87CA267","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-28","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 94,193,000,000 United States dollar\", as of 2025-12-28. Claim clm_249E6427F083, https://asof.is/claim/clm_249E6427F083, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_249E6427F083","accessed":"2026-11-08"},"kind":"money","predicate":"revenue","value":"94,193,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_249E6427F083","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-28","until":null,"published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 109,000,000 United States dollar\", as of 2025-12-28. Claim clm_845673D0E6C8, https://asof.is/claim/clm_845673D0E6C8, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_845673D0E6C8","accessed":"2026-11-08"},"kind":"money","predicate":"research_and_development","value":"109,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_845673D0E6C8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-28","until":"2026-03-29","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 19,709,000,000 United States dollar\", as of 2025-12-28 (until 2026-03-29). Claim clm_9D46DE0A4F23, https://asof.is/claim/clm_9D46DE0A4F23, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_9D46DE0A4F23","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"19,709,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9D46DE0A4F23","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-28","until":"2026-03-29","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 199,210,000,000 United States dollar\", as of 2025-12-28 (until 2026-03-29). Claim clm_AFEC68E6D52E, https://asof.is/claim/clm_AFEC68E6D52E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_AFEC68E6D52E","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"199,210,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AFEC68E6D52E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-11"}},{"date":"2025-12-28","until":"2026-03-29","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 81,544,000,000 United States dollar\", as of 2025-12-28 (until 2026-03-29). Claim clm_BDE73F201969, https://asof.is/claim/clm_BDE73F201969, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_BDE73F201969","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"81,544,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BDE73F201969","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-02-06","until":"2026-04-17","published":"2026-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,898,936 shares\", as of 2026-02-06 (until 2026-04-17). Claim clm_DD98E84FA8C5, https://asof.is/claim/clm_DD98E84FA8C5, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/0000200406-26-000016-index.htm.","url":"https://asof.is/claim/clm_DD98E84FA8C5","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,409,898,936 shares","status":"superseded","assertable":true,"id":"clm_DD98E84FA8C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-11"}},{"date":"2026-03-29","until":"2026-06-28","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 24,062,000,000 United States dollar\", as of 2026-03-29 (until 2026-06-28). Claim clm_1D62C3B5C845, https://asof.is/claim/clm_1D62C3B5C845, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_1D62C3B5C845","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"24,062,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D62C3B5C845","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-03-29","until":"2026-06-28","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,235,000,000 United States dollar\", as of 2026-03-29 (until 2026-06-28). Claim clm_636E850C3608, https://asof.is/claim/clm_636E850C3608, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_636E850C3608","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,235,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_636E850C3608","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-03-29","until":"2026-06-28","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 21,688,000,000 United States dollar\", as of 2026-03-29 (until 2026-06-28). Claim clm_A03ED0E3994C, https://asof.is/claim/clm_A03ED0E3994C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_A03ED0E3994C","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"21,688,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A03ED0E3994C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-03-29","until":"2026-06-28","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 200,894,000,000 United States dollar\", as of 2026-03-29 (until 2026-06-28). Claim clm_B407CB3DF742, https://asof.is/claim/clm_B407CB3DF742, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_B407CB3DF742","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"200,894,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B407CB3DF742","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-03-29","until":"2026-06-28","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 81,186,000,000 United States dollar\", as of 2026-03-29 (until 2026-06-28). Claim clm_FEC71A3FF62B, https://asof.is/claim/clm_FEC71A3FF62B, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_FEC71A3FF62B","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"81,186,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEC71A3FF62B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-04-17","until":"2026-07-17","published":"2026-04-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,216,971 shares\", as of 2026-04-17 (until 2026-07-17). Claim clm_985E1E06763A, https://asof.is/claim/clm_985E1E06763A, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000087/0000200406-26-000087-index.htm.","url":"https://asof.is/claim/clm_985E1E06763A","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,216,971 shares","status":"superseded","assertable":true,"id":"clm_985E1E06763A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-04-22"}},{"date":"2026-06-28","until":"2026-09-27","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 25,310,000,000 United States dollar\", as of 2026-06-28 (until 2026-09-27). Claim clm_0C91EDAB21CE, https://asof.is/claim/clm_0C91EDAB21CE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_0C91EDAB21CE","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"25,310,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0C91EDAB21CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-06-28","until":"2026-09-27","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,534,000,000 United States dollar\", as of 2026-06-28 (until 2026-09-27). Claim clm_59B90AEE5B12, https://asof.is/claim/clm_59B90AEE5B12, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_59B90AEE5B12","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"5,534,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59B90AEE5B12","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-06-28","until":"2026-09-27","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 201,061,000,000 United States dollar\", as of 2026-06-28 (until 2026-09-27). Claim clm_79297CC7C501, https://asof.is/claim/clm_79297CC7C501, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_79297CC7C501","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"201,061,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_79297CC7C501","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-06-28","until":"2026-09-27","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 20,422,000,000 United States dollar\", as of 2026-06-28 (until 2026-09-27). Claim clm_8805C678B558, https://asof.is/claim/clm_8805C678B558, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_8805C678B558","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"20,422,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8805C678B558","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-06-28","until":"2026-09-27","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 84,971,000,000 United States dollar\", as of 2026-06-28 (until 2026-09-27). Claim clm_FCA0DD2539AE, https://asof.is/claim/clm_FCA0DD2539AE, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_FCA0DD2539AE","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"84,971,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FCA0DD2539AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-07-17","until":"2026-10-15","published":"2026-07-23","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,898,597 shares\", as of 2026-07-17 (until 2026-10-15). Claim clm_333CD55899D7, https://asof.is/claim/clm_333CD55899D7, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000153/0000200406-26-000153-index.htm.","url":"https://asof.is/claim/clm_333CD55899D7","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,409,898,597 shares","status":"superseded","assertable":true,"id":"clm_333CD55899D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-07-23"}},{"date":"2026-09-27","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 25,399,000,000 United States dollar\", as of 2026-09-27. Claim clm_0641FC210206, https://asof.is/claim/clm_0641FC210206, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0641FC210206","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_revenue","value":"25,399,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_0641FC210206","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2026, filed 2026-10-21"}},{"date":"2026-09-27","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 197,425,000,000 United States dollar\", as of 2026-09-27. Claim clm_0B98C34873D9, https://asof.is/claim/clm_0B98C34873D9, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_0B98C34873D9","accessed":"2026-11-08"},"kind":"money","predicate":"total_assets","value":"197,425,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_0B98C34873D9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-10-21"}},{"date":"2026-09-27","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 16,910,000,000 United States dollar\", as of 2026-09-27. Claim clm_B2E80FDC373C, https://asof.is/claim/clm_B2E80FDC373C, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_B2E80FDC373C","accessed":"2026-11-08"},"kind":"money","predicate":"cash_and_equivalents","value":"16,910,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B2E80FDC373C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-10-21"}},{"date":"2026-09-27","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 210,000,000 United States dollar\", as of 2026-09-27. Claim clm_DE9082D90894, https://asof.is/claim/clm_DE9082D90894, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_DE9082D90894","accessed":"2026-11-08"},"kind":"money","predicate":"quarterly_net_income","value":"210,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_DE9082D90894","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-10-21"}},{"date":"2026-09-27","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 81,529,000,000 United States dollar\", as of 2026-09-27. Claim clm_F6CBCD569325, https://asof.is/claim/clm_F6CBCD569325, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_F6CBCD569325","accessed":"2026-11-08"},"kind":"money","predicate":"total_equity","value":"81,529,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_F6CBCD569325","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-10-21"}},{"date":"2026-10-15","until":null,"published":"2026-10-21","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,407,310,266 shares\", as of 2026-10-15. Claim clm_7504E6D195B0, https://asof.is/claim/clm_7504E6D195B0, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/0000200406-26-000197-index.htm.","url":"https://asof.is/claim/clm_7504E6D195B0","accessed":"2026-11-08"},"kind":"money","predicate":"shares_outstanding","value":"2,407,310,266 shares","status":"valid","assertable":true,"id":"clm_7504E6D195B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-10-21"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)","sec-filing":"parsed from the SEC filing"}}}